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ABSTRACT 
Animal research involving the effects of anxiolytics on theta oscillations has 
focused on changes in theta frequency in the hippocampus, rather than effects in medial 
entorhinal cortex (MEC), which provides the cortical input to the hippocampus and is the 
source of Type I (movement-related) theta rhythm.  Neurons coding spatial location, 
including “grid cells,” are found in the MEC and aspects of their spatial modulation have 
been linked to theta rhythm in different ways.  Theta frequency recorded in the local field 
potential (LFP) is also strongly correlated with running speed and is used in specific 
computational models of grid cell firing. 
Manipulating theta frequency through administration of anxiolytics offers a 
unique method of examining regulation of the LFP frequency in the MEC, along with the 
effects of changes in theta frequency on grid cells and other cell types in the region.  In 
addition, the role of the medial septum (MS), which is necessary for theta rhythm in both 
the MEC and hippocampus, can be investigated by infusing anxiolytics directly into the 
MS.  In this thesis, two separate anxiolytic drugs were tested: a serotonin 1A receptor 
agonist, 8-OH-DPAT, and a classic benzodiazepine, diazepam, the results of which are 
  xi 
described in chapters 2 and 3, respectively.  Systemic injections of either drug caused a 
reduction in theta frequency across all running speeds, resulting in a decrease in the y-
intercept of the linear fit to the plot of theta frequency over different running speeds.  
However, only MS infusion of 8-OH-DPAT, not diazepam, significantly decreased the y-
intercept in the MEC. 
Together, these results expand detection of anxiolytic drug action on theta 
frequency to a new structure, the MEC, when drugs are given systemically, but 
demonstrate a dissociation between drug types in their ability to produce effects when 
infused into the MS.  Grid cell firing patterns were unaffected and very few effects were 
found in single unit firing across different cell types.  Overall, these results support 
predictions made by specific computational models and highlight the involvement of the 
MEC in the anxiolytic-induced decrease in theta frequency phenomenon uniquely tied to 
the action of these drugs.  
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CHAPTER 1: Introduction 
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1.1. Spatially modulated activity 
The ability to track where one is in an environment and maintain numerous 
mental representations of space is not only necessary for survival but also adds to the 
richness of one’s experience.  The first examples of spatially modulated cells were 
reported by O’Keefe and Dostrovsky (1971) when they recorded from individual units in 
the hippocampus in awake, behaving rats as they traversed an environment.  They found 
that some of the isolated units would only fire action potentials when the rat was in a 
specific location of the environment, cells later deemed “place units” (O’Keefe and 
Dostrovsky, 1971; O’Keefe, 1976).  Since then, research has expanded to look for 
navigation-related neuronal activity in other areas of the brain, such as finding cells that 
fire when an animal is facing a certain direction (“head direction,” or HD, cells) in the 
presubiculum (Taube et al., 1990) and many other locations including the medial 
entorhinal cortex (MEC) (Sargolini et al., 2006). 
More recently, spatially modulated cells were found that fire in multiple, but very 
specific locations in an environment (“grid cells”), residing in the dorsocaudal area of the 
MEC (Fyhn et al., 2004; Hafting et al., 2005) and pre- and parasubiculum (Boccara et al., 
2010).  Specifically, as a rat visits locations in an environment, these cells fire in a grid-
like pattern corresponding to the corners of tightly packed equilateral triangles 
tessellating the entire traversed environment.  Lastly, another type of spatially modulated 
cell was found that fires along borders of an environment (“border cells,” in MEC and 
parasubiculum) (Solstad et al., 2008) or in response to boundaries (“boundary vector 
cells,” in subiculum) (Barry et al., 2006; Lever et al., 2009).  Remarkably, all of these 
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cells (place, grid, HD, and border/boundary cells) track changes to and across 
environments, by “remapping” or changing their firing rate and/or receptive fields in new 
environments or by matching directions of rotations made to an environment (Bostock et 
al., 1991; Hafting et al., 2005; Leutgeb et al., 2005; Fyhn et al., 2007; Solstad et al., 
2008).  All of these types of cells are found throughout the hippocampus, pre- and 
parasubiculum, and MEC areas of the brain; regions that unsurprisingly form a highly 
interconnected circuit. 
1.2. Circuit of brain regions involved in representing space 
The entorhinal cortex is thought to be the gateway between cortical areas of the 
brain and the hippocampus.  Its six layers are often referred to as superficial (I-III) or 
deep (IV-VI).  Layer IV (lamina dissecans) is largely devoid of cell bodies.  The MEC is 
located in the caudal portion of the temporal lobe and provides almost all of the 
neocortical input to the hippocampus.  The entorhinal cortex is commonly divided into 
two main regions: the caudomedial portion and the rostrolateral portion, or the MEC and 
the lateral entorhinal cortex (LEC), respectively (Witter et al., 1989).  The MEC contains 
many spatially modulated cells of interest, while the LEC provides largely non-spatial 
and “item-oriented” input to the hippocampus (Hargreaves et al., 2005; Deshmukh and 
Knierim, 2011).  The dorsocaudal region of MEC, where grid cells are found, receives 
the most cortical input from the occipital regions, with other strong innervation coming 
from parietal, temporal, cingulate and frontal regions as well (Burwell and Amaral, 1998).  
In terms of subcortical input it receives projections from mainly the claustrum and dorsal 
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thalamus, with a smaller percent from the amygdala, olfactory areas, medial septum, 
hypothalamus, ventral thalamus, and basal ganglia (Kerr et al., 2007). 
1.2.1. Entorhinal-Hippocampal circuit 
Superficial layers of the MEC receive the above sensory input and cells in these 
layers send projections targeting the hippocampus primarily via the perforant pathway.  
Through this pathway, the middle one third of the molecular layer of septal (dorsal) 
dentate gyrus (DG) and Cornu Ammonis 3 (CA3) stratum lacunosum moleculare receive 
a large portion of MEC projections, arising from layer II cells (Steward and Scoville, 
1976; Witter and Amaral, 1991; Dolorfo and Amaral, 1998; Witter et al., 2000).  
Furthermore, MEC layer III cells project to the molecular layers of the proximal part 
(relative to the DG in the transverse plane) of CA1 and distal part of subiculum (Steward, 
1976; Witter and Amaral, 1991).  While deeper layers of the entorhinal cortex do make 
up a component of this hippocampal innervation as well, they comprise a vastly smaller 
portion (Witter and Amaral, 1991; Witter et al., 2000).   
Within the hippocampus, information is passed from DG to CA3 to CA1, which is 
then passed out to the entorhinal cortex directly or through the subiculum.  The DG 
granule cell axons (mossy fibers) provide glutamatergic input to the dendrites of CA3 
pyramidal cells of the molecular layer (Blackstad and Kjaerheim, 1961; Terrian et al., 
1990).  CA3 then projects to CA1 via Schaffer collaterals, closing out this classic 
“trisynaptic loop.”   
In contrast to the extensive entorhinal projections throughout all hippocampal 
fields, projections from the hippocampus to entorhinal cortex are much more selective in 
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origin, arising exclusively from CA1 and subiculum.  The proximal area of CA1 projects 
to the distal area of the subiculum, both of which project to mainly deeper layers (layers 
V-VI) of MEC (van Groen et al., 1986; Witter et al., 1989, 2000; Tamamaki and Nojyo, 
1995; Naber et al., 2001). 
The subiculum also projects to the pre- and parasubiculum (Witter et al., 1989). 
These areas send projections to principal neurons in all layers of the MEC (Canto et al., 
2012), likely passing on head direction information from the vestibular system to the 
MEC through this pathway (Taube, 2007; Boccara et al., 2010).   
Within the MEC, the deeper layers complete this circuit by sending mostly (but 
not exclusively) excitatory projections back to principal cells and interneurons in the 
superficial layers (Witter et al., 1989; Dolorfo and Amaral, 1998; van Haeften et al., 
2003), and out to the rest of the cortex, mainly through layer V (Insausti et al., 1997).   
1.2.2. Septal projections 
The MEC is strongly innervated by the medial septum (MS).  The MS and 
vertical limb of the diagonal band of Broca (dbB) provide the cholinergic input into the 
MEC (Alonso and Köhler, 1984), along with providing γ-aminobutyric acid (GABA)- 
containing (GABAergic) (Köhler et al., 1984) and glutamate-containing (glutamatergic) 
(Manns et al., 2001) projections.  These axons from the MS/dbB project mainly to layers 
II and V of the MEC and the LEC, and cells in these layers also project back to the MS 
(Alonso and Köhler, 1984; Gaykema et al., 1990; Canto et al., 2008).   
Similarly, projections from the MS also strongly innervate the hippocampus and 
stem from mainly cholinergic and GABAergic neurons (Köhler et al., 1984; Wainer et al., 
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1985; Freund and Antal, 1988), with the cholinergic projections making up under half of 
the hippocampal innervation (Baisden et al., 1984; Wainer et al., 1985).  GABA-
containing neurons in the MS/dbB innervate GABA-containing interneurons throughout 
the hippocampus; activation of these afferents likely causes disinhibition of the principal 
cells in the hippocampus (Freund and Antal, 1988; Krnjević et al., 1988).  These 
GABAergic projections were predominantly found in strata oriens and radiatum layers of 
CA3 and the hilus and granule cell layer of dentate gyrus, though some contacts were 
seen in all layers (Freund and Antal, 1988).  Non-GABA-containing (presumably 
cholinergic) axons from the MS are reported to contact mostly (though not exclusively) 
non-GABA-containing dendritic shafts of pyramidal and granule cells though sometimes 
were seen in the stratum lacunosum moleculare of CA1 and CA3 (Freund and Antal, 
1988). 
Additionally, the hippocampus sends projections back to the MS.  This pathway is 
made up by a majority of GABAergic projection neurons from CA1 that innervate mostly 
GABAergic (few cholinergic) MS cells (Toth et al., 1993) along with some MS 
cholinergic projection cells (Gaykema et al., 1991).  Overall, these brain regions form a 
strongly interconnected circuit, giving rise to characteristic rhythms throughout these 
areas. 
1.3. Prominent theta rhythmicity is found throughout these regions 
Throughout the MS and hippocampal formation is a prominent 6-10 Hz 
oscillation, or theta rhythm, which can be found in the local field potential (LFP) and 
rhythmicity of single unit firing.  It is particularly striking throughout the hippocampus 
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(Green and Arduini, 1954; Vanderwolf, 1969; Bland, 1986), MEC (Mitchell and Ranck, 
1980; Alonso and García-Austt, 1987a), and MS (Petsche et al., 1962; King et al., 1998).   
1.3.1. Local field potential 
The LFP reflects the fluctuations in summed currents across a large number of 
extracellularly recorded cells.  The main source of this is thought to be through the 
synaptic currents from many cells active during overlapping times, producing a 
measurable current (Buzsáki et al., 2012).  Hippocampal theta rhythm is especially 
prominent in the LFP when rodents perform “voluntary” (as opposed to automatic) 
behaviors, such as walking, and during REM sleep (Vanderwolf, 1969; Whishaw and 
Vanderwolf, 1973; Leung, 1984).  It is strongest around the hippocampal fissure, and 
both amplitude and phase of the oscillation change across different depths but not along 
the long axis of the hippocampus, ultimately resulting in a 180 degree phase difference 
between theta in CA1 and theta in dentate gyrus (Buzsáki et al., 1983; Bullock et al., 
1990; Buzsáki, 2002).  In line with the projections from MEC to hippocampus, MEC 
layer II theta rhythm is similar in phase to dentate theta while layer III theta aligns with 
CA1 theta phase, with a phase reversal occurring between layers II and III (Mitchell and 
Ranck, 1980). 
Two types of theta rhythm with distinguishing characteristics have been identified 
and named based on their response to anticholinergics: Type 1 (atropine-resistant) and 
Type 2 (atropine-sensitive).  Atropine-sensitive theta (Type 2) is slightly slower in 
frequency (4-7 Hz), can be found when the animal is immobile or while under urethane 
anesthesia, and is abolished by administration of the anticholinergic drug, atropine.  
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Conversely, atropine-resistant theta (Type 1) is abolished under urethane anesthesia and 
is found while the animal is mobile (Kramis et al., 1975).  The precise mechanisms 
underlying Type 1 theta remain unclear (Vertes and Kocsis, 1997; Buzsáki, 2002), 
though extensive research on the phenomenon has provided many clues. 
Current source density (CSD) analysis uses high-density recording probes to 
measure the currents that give rise to the LFP, by localizing current sinks (areas where 
positive charge enters the cells from the extracellular space) and sources (locations where 
positive charge leaves the neuron).  In the hippocampus, recordings demonstrate a strong 
sink in CA1 stratum lacunosum-moleculare (which receives perforant path input) coupled 
with a strong source in the pyramidal layer (through somatic inhibition), along with an 
additional sink in stratum radiatum (mediated by CA3 Schaffer collaterals) (Leung, 1979; 
Buzsáki et al., 1983).  Under urethane anesthesia or after bilateral removal of the 
entorhinal cortex, the stratum lacunosum-moleculare sink is attenuated or disappears, 
respectively, whereas the source-sink in the pyramidal layer and stratum radiatum are 
retained (Ylinen et al., 1995; Kamondi et al., 1998; Buzsáki, 2002).  While 
deafferentation of the entorhinal cortex cortical inputs does not overtly disrupt 
hippocampal theta, it does render it atropine-sensitive as atropine administration 
abolishes the rhythm (Buzsáki et al., 1983).  Furthermore, lesions of CA3 pyramidal cells 
do not affect hippocampal theta in CA1, even after atropine administration (Whishaw and 
Sutherland, 1982).  Overall, these data suggest the involvement of the entorhinal cortex in 
specifically Type 1 theta.   
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The MS also plays a large role in the production of theta rhythm and is often 
regarded as a rhythm pacemaker.  It is the common input to the hippocampus and MEC, 
putatively providing the atropine-sensitive theta still present after entorhinal 
deafferentation or lesions.  MS lesions disrupt theta oscillations in both the hippocampus 
(Andersen et al., 1979; Rawlins et al., 1979; Sainsbury and Bland, 1981) and the MEC 
(Mitchell et al., 1982).  Temporarily inactivating the MS pharmacologically also 
suppresses theta oscillations in the hippocampus (Mizumori et al., 1989) and MEC 
(Brandon et al., 2011; Koenig et al., 2011). Simultaneous hippocampal infusions of 
carbachol, a non-selective cholinergic agonist, and bicuculline, a GABA-A receptor 
antagonist, reverses the effect of MS inactivation in the hippocampus (Colom et al., 
1991), highlighting the importance of both cholinergic and GABAergic roles in the 
circuit. 
1.3.2. Single unit rhythmicity 
Theta rhythmicity can also be found in the rhythmic firing of action potentials by 
single neurons.  Cells in the MS (Petsche et al., 1962; King et al., 1998), hippocampus 
(Ranck, 1973), and MEC (Mitchell and Ranck, 1980) show theta rhythmicity in the 
autocorrelations of their spiking.  This rhythmic spiking coincides with phases of theta 
recorded in the LFP.  In the hippocampus in urethane anesthetized animals, CA1 
pyramidal cells fire around the trough of CA1 pyramidale theta (peak of dentate theta) 
while interneurons show the inverse relationship, firing at opposite phases unless driven 
recurrently by sharp waves (Buzsáki et al., 1983; Fox et al., 1986; Skaggs et al., 1996).  
However, in the dentate gyrus, granule cells and most interneurons fired at the peak of 
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dentate theta, leading CA1 pyramidal cells by about 90 degrees (Buzsáki et al., 1983).  In 
the MS, putative GABAergic pacemaker cells fire synchronously with hippocampal theta, 
albeit with different phase relationships in comparison to other nearby MS theta cells 
(Petsche et al., 1962; Gogolák et al., 1968; King et al., 1998).  Neurons in the MEC also 
fire phase locked to theta oscillations (Mitchell and Ranck, 1980; Alonso and García-
Austt, 1987b; Chrobak and Buzsáki, 1998).  Theta rhythmic cells in layers II and III 
demonstrate phase locking to the negative phase of CA1 theta (positive peak of dentate 
theta) (Quirk and Stewart, 1988; Stewart et al., 1992).   
Some cells fire action potentials progressively earlier in relation to theta phase 
across successive cycles as the animal travels through a given cell’s receptive field, 
deemed phase precession.  This was first reported in place cells (O’Keefe and Recce, 
1993; Skaggs et al., 1996) and has been found in grid cells as well (Hafting et al., 2008; 
Climer et al., 2013).  Evidence suggests that the MEC plays a critical role in this firing 
pattern since grid cells still phase precess after hippocampal inactivation (Hafting et al., 
2008) whereas MEC inactivation disrupts this phenomenon in place cells (Schlesiger et 
al., 2015).  Furthermore, resetting the phase of hippocampal theta by briefly inhibiting 
recorded cells via electric shock led to the cells returning to fire at appropriate phases of 
theta for the given location of the animal, suggesting the involvement of extrinsic 
mechanisms (Zugaro et al., 2005).  MS inactivation greatly diminishes theta rhythmicity 
in hippocampal (Koenig et al., 2011) and MEC (Jeffery et al., 1995; Brandon et al., 2011; 
Koenig et al., 2011) neurons, highlighting its role in pacemaking these two anatomical 
targets. 
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1.4. Theta rhythm is also involved with representing space 
Theta rhythm has been linked to aspects of navigation in a number of ways.  In 
order to effectively track changes in position, for example as reflected in the precession 
of theta rhythmic spikes to earlier phases of LFP theta as an animal passes through a 
spatial firing field, it must be able to account for changes in speed.  In fact, LFP theta 
frequency is strongly correlated with running speed in both the hippocampus (Sławińska 
and Kasicki, 1998) and MEC (Jeewajee et al., 2008).  Furthermore, different types of 
cells that track aspects of navigation, such as place cells, grid cells, head direction cells, 
and border/boundary cells show theta rhythmicity in their firing and are often phase 
locked or precess in relation to LFP theta (O’Keefe and Recce, 1993; Skaggs et al., 1996; 
Hafting et al., 2008; Solstad et al., 2008; Mizuseki et al., 2009; Boccara et al., 2010).  
Temporarily inactivating the MS pharmacologically reduces MEC theta power and 
disrupts the spatially periodic firing pattern of grid cells in the MEC (Brandon et al., 
2011; Koenig et al., 2011).   
1.4.1. Grid scale and theta rhythm 
The receptive fields, or grid fields, of grid cells increase in size and spacing (grid 
scale) along the dorsal to ventral axis of the MEC (Brun et al., 2008).  This scale increase 
along the axis correlates with the period of the subthreshold membrane potential 
oscillation recorded in layer II MEC stellate cells in vitro (Giocomo et al., 2007).  
Furthermore, the frequency of the rhythmicity of grid cell firing is inversely correlated 
with increasing grid field sizes (Jeewajee et al., 2008).  Grid scale also increases in 
response to a novel environment, while the rhythmicity of firing decreases in frequency 
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(period increases) (Barry et al., 2012).  MEC theta frequency is positively correlated with 
running speed (Jeewajee et al., 2008); the slope of this relationship decreases in the 
hippocampus when an animal is introduced to a new environment (Wells et al., 2013).  
This could be in response to increased acetylcholine (ACh) levels as novelty has been 
linked to increased hippocampal release of this neuromodulator (Inglis et al., 1994; 
Acquas et al., 1996).  Furthermore, muscarinic ACh receptor activation decreases the 
frequency of subthreshold oscillations and membrane potential resonance of MEC layer 
II stellate cells (Klink and Alonso, 1997; Heys et al., 2010).  Similar to the novelty-
induced decrease in slope, multiple same day exposures of a rat to a familiar environment 
can produce small increases in slope of MEC firing to running speed with each exposure, 
in both the hippocampus and the MEC (Jeewajee et al., 2008; Newman et al., 2013; 
Wells et al., 2013). 
1.5. Computational models 
A number of computational models exist that offer explanations of mechanisms 
underlying spatial representation in the brain, offering testable hypotheses to potentially 
support their theories.  In the grid cell literature, two classes of models were borrowed 
from place cell models to explain this phenomenon: oscillatory interference models 
(OIMs) (O’Keefe and Recce, 1993; O’Keefe and Burgess, 2005) and continuous attractor 
network (CAN) models (Samsonovich and McNaughton, 1997).  While they tend to be 
contrasted against each other, these models are not necessarily mutually exclusive as they 
approach the phenomenon through different but not inherently contradictory methods.  In 
fact, the addition of features from CAN models to OIMs could improve aspects of OIMs 
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(Burgess, 2008; Bush and Burgess, 2014).  Iterations of models within each class have 
attempted to explain biological data to varying degrees of success, and more recently 
have inspired different, hybrid models to emerge.  
1.5.1. Oscillatory interference models 
 OIMs take advantage of the prominent theta oscillations present throughout the 
hippocampus and entorhinal cortex, found in both the LFP and in the rhythmicity of 
single units.  The general principle behind these models is that two slightly different 
oscillations, for example found in the LFP and in a given cell’s subthreshold membrane 
potential oscillations, produce constructive and deconstructive interference when the 
peaks of their oscillations align or cancel out, respectively.  During times of peak 
alignment, this drives the given neuron to spike, producing a grid like pattern (via various 
mechanisms depending on the model).  Importantly, both oscillations must increase in 
frequency with running speed in order to maintain consistent firing patterns regardless of 
velocity (though at different rates of increase), matching biological data (Jeewajee et al., 
2008).  Specifically, the general model states that LFP theta reflects the mean theta 
frequency of all velocity controlled oscillators (VCOs), or cells in which the membrane 
potential oscillation increases with movement velocity in a preferred direction (Burgess 
et al., 2007; Burgess, 2008; Jeewajee et al., 2008).  Therefore, while LFP theta increases 
with running speed, the intrinsic theta rhythmic frequency of grid cells increases faster as 
it is driven by the currently active VCOs that have a preferred direction aligned with the 
current running direction of the rat (Burgess, 2008; Jeewajee et al., 2008).  These models 
use these different oscillation frequencies to produce the different scales of grid cell 
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firing found along the dorsoventral axis, and predicted the later finding that frequency of 
intrinsic subthreshold membrane potential oscillations decreases in cells along this axis 
(O’Keefe and Burgess, 2005; Giocomo et al., 2007).   
 Based on the OIM, Burgess (2008) suggested that the different mechanisms 
underlying the two components of theta, Type 1 (atropine-resistant) and Type 2 
(atropine-sensitive), are also separately involved with the slope and intercept, 
respectively, of the relationship between theta frequency and running speed (Burgess, 
2008).  A change in the slope, but not the intercept, of this relationship is predicted to 
produce a change in grid scale, relating to specifically atropine-resistant theta.  While the 
MS plays a role in both components, the MEC is involved in atropine-resistant as well.  
This prediction is supported by the findings that exposure to a novel environment 
increases grid scale and decreases the slope of hippocampal theta frequency plotted 
across running speeds (Barry et al., 2012; Wells et al., 2013). 
1.5.2. Continuous attractor network models 
 The finding that nearby grid cells share similar scale and orientation but offset 
phases suggests the possibility of local recurrent connections influencing activity.  
Broadly, CAN models utilize this through modeling a sheet of connected cells with a 
traveling activity bump activating specific cells, tracking the animal’s running speed and 
direction (Fuhs and Touretzky, 2006; McNaughton et al., 2006; Guanella and Verschure, 
2007; Burak and Fiete, 2009).  Each of these sets of grid cells would be independent from 
the other, a notion that could be supported by the evidence that different modules exist 
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throughout the MEC dorsoventral axis and respond differently to environmental 
manipulations (O’Keefe and Burgess, 2005; Stensola et al., 2012). 
1.5.3. Hybrid models 
Hybrid models often utilize aspects of both CAN models and OIMs to generate 
grid cell firing patterns.  Bush and Burgess (2014) explicitly combine the two models, 
while another model uses an interaction of traveling waves, using feedback from the grid 
cell population to the individual traveling wave inputs to produce attractor dynamics 
(Hasselmo and Brandon, 2012; Hasselmo and Shay, 2014).  One criticism of CAN 
models has been the inability to inherently produce phase precession, which was obtained 
using a hybrid model by Navratilova et al. (2012) through rebound activity from an 
afterdepolarization effect from previous spiking activity.  Hasselmo (2014) combined 
rhythmic input from the MS to generate rebound spiking activity in the MEC with the 
different resonance properties found in MEC neurons to produce spatially periodic firing 
with different grid field scales. 
1.6. Anxiolytic effects on theta frequency 
While grid field spacing and mean theta frequency have been correlated, evidence 
suggests it is not simply the decrease in mean that is important, but the effect on the 
dissociable components of theta frequency: the intercept and slope of the relationship of 
theta frequency across running speeds.  Type II theta is present during arousal and 
anxiety (Sainsbury et al., 1987), which Burgess (2008) links to the intercept.  Since the 
OIM predicts that slope influences grid field scale, a decrease in mean theta frequency 
 
 
 
16 
through effects on the intercept would not affect grid field scale.  This can be directly 
tested through the use of anxiolytics.  Systemic administration of anxiolytics, such as 
benzodiazepines (BDZs) and serotonin 1A receptor (5-HT1A) agonists reduces the 
frequency of theta rhythm recorded in the hippocampus (McNaughton et al., 1986; Coop 
and McNaughton, 1991; Wells et al., 2013).  Specifically, they both reduce the y-
intercept of the relationship between theta frequency and running speed (Wells et al., 
2013).  Based on predictions by Burgess (Burgess, 2008; Wells et al., 2013), systemic 
administration of anxiolytics should impact only Type II theta because Type II theta is 
altered by arousal and anxiety, and therefore Burgess predicts that anxiolytics should 
reduce the intercept of the theta frequency correlations across running speeds and leave 
grid field scale intact. 
 The mechanisms underlying the effects of anxiolytics on theta frequency are still 
unclear.  It is difficult to pinpoint exactly what produces the decrease in frequency, 
considering different classes of anxiolytics work through entirely different 
neurotransmitter systems.  Furthermore, they are independent in that antagonists 
preventing effects within their own class have no effect outside their type.  The 5-HT1A 
antagonist, pindolol, reduces the effect of 5-HT1A agonists, 8-OH-DPAT and buspirone, 
but not the benzodiazepine, chlordiazepoxide (CDP) (Coop and McNaughton, 1991; 
Coop et al., 1992).  Similarly, the benzodiazepine receptor antagonist, flumazenil, 
decreases the effect of CDP, but has no effect on the 5-HT1A agonist, buspirone (Coop et 
al., 1992).   
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Despite working through entirely different neurotransmitter systems, both classes 
of anxiolytics have similar effects on hippocampal theta (McNaughton and Coop, 1991), 
though it is not known if they similarly impact activity in the MEC or if these effects are 
mediated through the MS, which provides theta rhythmic input to the MEC and 
hippocampus.  In the experiments presented here, the potential influence of anxiolytics on 
the physiology of the MEC will be tested by infusing anxiolytics directly into the MS and 
comparing changes in MEC activity to effects of systemic injections of the same 
anxiolytics.   
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CHAPTER 2: Effects of systemic administration and MS infusion of a serotonergic 
anxiolytic on MEC activity1 
 
 
 
 
 
 
 
 
 
1Monaghan CK, Chapman IV GW, Hasselmo ME.  In prep. 
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2.1. Introduction  
Research involving the effects of anxiolytics on theta oscillations has focused on 
changes in theta frequency within the hippocampus, with very little on the effects on 
medial entorhinal cortex (MEC) activity, which provides the cortical input to the 
hippocampus and is reportedly the source of Type I theta oscillations (Buzsáki et al., 
1983).  Furthermore, strikingly spatially modulated cells, grid cells, are found in the 
MEC and have been correlated in many ways to theta frequency (Hafting et al., 2005; 
Giocomo et al., 2007; Jeewajee et al., 2008; Barry et al., 2012).  The serotonin (5-
hydroxytryptamine, 5-HT) 1A receptor agonists make up a separate class of anxiolytics 
that work through a completely different system than the classic BDZs.  While they offer 
the same benefits of the standard anxiolytics and also reduce hippocampal theta 
frequency, they do so through non-GABAergic mechanisms (McNaughton and Coop, 
1991; Coop et al., 1992).  
5-HT1A receptors appear in high concentrations throughout the medial septum 
(MS), which provides theta rhythmic input to both the MEC and the hippocampus, as 
well as within the MEC and hippocampus (Pazos and Palacios, 1985; Kia et al., 1996; 
Lüttgen et al., 2005).  Activation of 5-HT1A receptors mediates inhibitory transmission 
through G-protein-coupled potassium (K+) channels (Hoyer et al., 2002).  In the raphe 
nuclei, which provide serotonergic innervation throughout the brain, 5-HT1A receptors 
are somatodendritic and activation of these autoreceptors has an inhibitory effect on the 
presynaptic neuron (Vergé et al., 1985; Sprouse and Aghajanian, 1987).  5-HT1A 
receptors are also located postsynaptically on different neuron types throughout the brain, 
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including cholinergic and GABAergic cells in the MS, and activation of these receptors 
has a hyperpolarizing effect (Kia et al., 1996; Hoyer et al., 2002; Lüttgen et al., 2005).   
The MS, hippocampus, and MEC receive dense innervation from the median 
raphe nuclei, through both serotonin- and non-serotonin-containing processes (Köhler 
and Steinbusch, 1982; Köhler et al., 1982).  Furthermore, the same neuron in the raphe 
may influence downstream activity in both the hippocampus and the MEC 
simultaneously, suggesting potential similarities in modulation of activity (Köhler and 
Steinbusch, 1982).  Infusion of serotonergic agonists into the median raphe disrupts theta 
oscillations in the hippocampus (Kinney et al., 1994; Vertes et al., 1994) while inhibiting 
the median raphe enhances hippocampal theta (Kinney et al., 1995).  Administration of 
serotonergic anxiolytics has been extensively shown to reduce hippocampal theta 
frequency elicited via reticular formation stimulation in anesthetized animals and after 
administration in awake behaving animals (Coop and McNaughton, 1991; McNaughton 
and Coop, 1991; McNaughton et al., 2007; Wells et al., 2013).  However, it is not known 
how this might affect activity in the MEC—both in terms of LFP effects and on the firing 
of single units, such as grid cells, which show spacing of firing fields that is correlated 
with theta frequency and fire theta rhythmically as well (Giocomo et al., 2007; Brun et al., 
2008; Jeewajee et al., 2008; Barry et al., 2012).  
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2.2. Materials and Methods 
2.2.1. Subjects 
Male Long-Evans rats (Charles River Laboratories) weighing between 350-450 
grams at surgery were used for these studies.  All experimental procedures were approved 
by the Institutional Animal Care and Use Committee for the Charles River Campus at 
Boston University.  Rats were housed individually in plexiglass cages, maintained on a 
12-hour light/12-hour dark cycle (testing always occurred during the light cycle), and 
were maintained at ~85% of their ad libitum weight.  Prior to surgery, rats were 
habituated to the experimenter and testing room.  The animals were trained to forage in 
an open field environment (1 m by 1.5 m) for pieces of Froot Loops (Kellogg’s).  One 
wall of the otherwise black painted environment was white to provide stable landmark 
information; cues surrounding the environment were present to provide distal information 
as well. 
2.2.2. Implant 
Rats were implanted with recording drives housing up to 16 individually 
moveable tetrodes (four 12.7 μm nichrome wires spun together) and 4 reference tetrodes, 
aimed at the MEC.  Tetrodes were gold plated to bring down the impedance to <150 
kOhm.  The exit of the drive was angled at ~25 degrees in the posterior direction in order 
to implant just anterior of the transverse sinus. 
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2.2.3. Surgery 
Rats were anesthetized with isoflurane and given an injection of a 
ketamine/xylazine/acepromazine cocktail and buprenorphine; depth of anesthesia was 
monitored at least every 15 minutes by checking breathing and confirming lack of 
response to a toe pinch.  An injection of atropine was given to prevent fluid buildup in the 
lungs.  After the initial incision, the skull area was cleared of fascia and approximately 10 
holes were drilled to attach anchor screws into the skull; 1-2 ground screws were placed 
over the cerebellum.  Two craniotomies were performed: one to implant a drug delivery 
cannula (from Bregma: 0.5 mm anterior, 3.0 mm lateral; implanted at 25 degrees 
medially, lowered 6.0 mm from brain surface) and the second as the implant site (left 
hemisphere; most lateral and posterior corner grazes where the left bone ridge and 
lambda suture meet).  The implant was secured in place using Kwik-Sil and dental acrylic.  
Tetrodes were lowered 2-3 mm from the dorsal surface at surgery.  Animals were 
allowed one week to fully recover after surgery before experiments began. 
2.2.4. Neural recordings 
Animals were tested daily in the open field during recordings to search for grid 
cells, conjunctive grid-by-head-direction cells, border cells, and theta rhythmic cells.  
Once theta rhythmic cells and theta oscillations in the LFP were recorded, tetrodes were 
lowered a maximum of ~35 μm/day; experiments were never done on days tetrodes were 
turned in order to maximize the likelihood of recording the same cells across sessions.  
Neural signals were preamplified by unity-gain operational amplifiers located on the head 
of the animal.  Signals were linked to digital amplifiers and amplified (5,000-20,000X) 
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and bandpass filtered (1-500 Hz) by the 64-channel Cheetah Digital Lynx acquisition 
system (Neuralynx Corp., Bozeman, MT). When a signal crossed threshold all four 
channels of the tetrode were digitized at 32 kHz and recorded. Position, head direction, 
and velocity data were calculated from a red (front) and green (back) diode positioned on 
the recording head stage and sampled at 30 Hz.  Position was determined as the centroid 
of the diodes. LFP activity was collected at 32 kHz and downsampled to 508 Hz.  LFP 
traces obtained from the MEC were recorded from a single lead of a tetrode and 
referenced to the animal ground or to a cortical electrode that did not show theta 
oscillations when referenced to ground. 
2.2.5. Histology 
When possible, final tetrode positions were marked before sacrificing the animal 
by passing current through tetrodes that had recorded grid cells.  Animals were overdosed 
with isoflurane and perfused intracardially with saline followed by 4% paraformaldehyde.  
Brains were extracted and stored in 4% paraformaldehyde at 6 degrees C for at least 24 
hours.  Approximately 72 hours before slicing, brains were transferred into a 30% 
sucrose solution.  The brain was cut to separate the MS and MEC portions; the MEC was 
sliced along the sagittal plane to visualize tetrode tracks, while the MS was sliced along 
the coronal plane to confirm cannula placement.  Sections were mounted on gelatin-
subbed glass slides and stained with cresyl violet. 
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2.2.6. Experimental design 
One to two 20-minute pre-drug recording sessions were performed prior to drug 
injection or infusion.  After drug administration, recording sessions were performed up to 
45 minutes in duration to ensure adequate coverage of the environment.  This session 
began within 10 minutes following drug administration, except in the case of muscimol 
infusion (15 minutes post).  A twenty-minute recovery session was recorded 3-6 hours 
post-drug administration and 24 hours later, to confirm return to normal activity.  
Multiple experiments, including administration of different types of drugs, were 
performed in a rat for as long as a given grid cell could be well-isolated, however there 
was a minimum of 48 hours between all drug and vehicle administrations.  When single 
units of interest could no longer be isolated, tetrodes were moved down and screening for 
cells of interest began again. 
2.2.7. Drugs and drug administration 
Drugs were administered either systemically through intraperitoneal injection or 
intracranially into the MS via the implanted guide cannula.  Prior to an infusion, the 
dummy cannula was removed to allow access to the guide cannula.  An injector cannula 
(33 gauge), extending 1 mm beyond the guide cannula, was filled with the drug or 
vehicle and lowered through the guide cannula and into the MS.  A microinfusion pump 
infused 0.3-0.5 μL of the solution (depending on the experiment) at a rate of 0.125 
μL/min.  The injector cannula was left inserted for two minutes after the infusion to allow 
the drug to diffuse throughout the tissue.  The injector cannula was then removed and 
replaced with a sterilized dummy cannula. 
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Volume-matched vehicle controls were performed for both systemic injections (1 
mL/kg) and infusions (0.5 μL).  The 5-HT1A receptor agonist, 8-OH-DPAT (Sigma), 
was mixed in sterile phosphate buffered saline (PBS) to make a concentration of 100 
μg/mL and administered at 75 μg/kg systemically or infused at 2.4 μg or 4 μg of an 8 
μg/uL concentration.  Before commencing the first infusion experiment in a rat, a 
muscimol infusion (0.5 μL of 0.5 μg/μL) was performed once a grid cell was recorded 
and/or when theta oscillations were present in the LFP to confirm loss of theta power and 
grid cell spatial periodicity (when grid cells were being recorded) in order to verify 
correct cannula placement.  If spatial periodicity and theta power were not disrupted, an 
injector needle with a 2 mm (instead of 1 mm) projection was tried, at least 48 hours later.  
If this was not successful either, the rat was not used for collecting infusion data. 
8-OH-DPAT systemic 
Effective doses of 8-OH-DPAT given via intraperitoneal injection reported in the 
literature range from 15 μg/kg up to 2.5 mg/kg (Table 2.1).  Different doses were tested 
for this work (50, 75, 100, and 150 μg/kg) and 75 μg/kg was found to be the highest dose 
that could be given without disrupting ambulation in most cases.  Injections were given 
within a range of 15 minutes to 30 minutes before the given experimental session began, 
in most cases.  When tested and reported, peak effects were achieved 30 or 45 minutes 
post administration (Klancnik et al., 1989; Coop et al., 1992) but in both experiments, 
near maximum levels were reported 15 minutes post-injection.  In this work, recordings 
typically began within 10 minutes post-injection. 
8-OH-DPAT infusion 
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Infusion amounts that produced effects range in the literature from 0.5 to 10 μg 
(Table 2.2).  Two amounts were tested in this work: 2.4 and 4 μg (0.3 μL and 0.5 μL of 8 
μg/μL concentration).  Similar to systemic administration, 2.4 μg was chosen because it 
impacted ambulation the least.  In all examined journal articles when it was reported, the 
experimental task began 10 minutes after infusion, which was the same for the 
experiments performed for this research. 
2.2.8. Analyses 
Cluster cutting across sessions 
After the completion of each recording session, single units were isolated using 
cluster cutting software (Offline Sorter, Plexon Inc.).  Single units were distinguished 
using peak amplitude and principal components for each waveform.  Stability of units 
was confirmed by tracking waveform profiles across the four leads of the tetrode and 
cluster position across recording sessions, comparing to the baseline session.  
Measurement of theta rhythm and running speed 
LFP activity was collected at 32 kHz and downsampled to 508 Hz.  Downsampled 
LFP was filtered using a second order butterworth bandpass filter with cutoff frequencies 
of 6-10 Hz for theta band.  Phase was estimated using the angle of the Hilbert transform 
of the filtered signal and instantaneous amplitude was estimated as the amplitude of the 
Hilbert transform.  The LFP channel used for analyses was chosen on an animal-by-
animal basis for each set of four recording sessions based on spectral properties from the 
baseline recording (Brandon et al., 2013).  For each channel the spectrum of LFP power 
was found, the peak within theta range determined, and divided by the mean signal, 
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giving the relative power within the theta band.  The LFP channel was then chosen as the 
channel with maximum theta to noise ratio for each rat's baseline session.  Theta 
frequency, amplitude, and power were calculated for 2.5 cm/s running speed bins and 
plotted from 5-30 cm/s.  Each rat's LFP signal was normalized to aid comparison between 
animals per Wells et al. (2013).  In brief, for each measure (frequency, amplitude, and 
power), the overall mean across all animals during baseline was calculated.  A 
normalization factor was determined on an animal-by-animal basis as the mean 
difference in the animal’s baseline signal from the population mean.  This normalization 
factor was applied across all sessions for each animal, giving a normalized signal.  This 
method accounts for a mean difference, but not speed modulated difference, in theta 
measures between animals. 
Measurement of single unit properties 
Spatial rate maps were constructed for a given unit by taking the number of spikes 
in 3.6 cm by 3.6 cm spatial bins and dividing by the amount of time spent in that bin.  
Rate maps were smoothed using a 5x5 bin pseudo-Gaussian kernel with a one-pixel 
standard deviation.  The spatial periodicity of grid cells was quantified with a “gridness” 
score and computed from the spatial autocorrelation of the smoothed rate maps.  For the 
gridness score calculated, “gridness 3,” the center peak was removed from the 
autocorrelation and if present, the six surrounding peaks found and cut out to make a 
donut.  If the grid shape was elliptical, it was distorted to create a circle.  The correlation 
was calculated for each 3 degree rotation of the donut to itself.  The gridness score is the 
difference between the correlation at the minimum peak of 60 or 120 degrees and the 
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maximum trough at 30, 90, or 150 degrees.  The grid field distance was determined from 
the spatial autocorrelation by calculating the average distance between the middle and six 
surrounding peaks, checked manually to ensure the proper fields were being detected and 
measured.   
Head direction firing properties of units were calculated by constructing a polar 
histogram of firing rates by head direction.  Spikes were put into bins of 6 degrees and 
divided by the amount of time spent facing that direction.  The mean resultant length 
(MRL) of the directionality of spiking was then calculated.   
The spatial information (SI) score reflects the degree to which a cell’s spiking can 
be used to predict the animal’s location.  It was calculated as in Cacucci et al. (2007) and 
expressed in bits/spike.  Correlation of the spatial rate maps for cells were calculated by 
finding the Pearson’s correlation coefficient between the baseline rate map and the 
following sessions for a given cell.   
Spike time autocorrelograms were created with time bins of 10 ms and 
normalized and clipped to the peak in the theta range (6-10 Hz). Autocorrelograms were 
then fit with the equation: 
y(t) =[a*(cos(ω*t)+1)+b]*exp(-|x|/τ1)+c*exp(-t2 /τ22 )) 
Where y(t) is the normalized autocorrelogram value, t is the time lag, a is an 
amplitude of rhythmicity, τ1 and τ2 are fall off constants, b and c are coefficients for theta 
rhythmicity and theta skipping, and ω is the intrinsic frequency of the cell. The theta 
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index was then defined as (a+b) over the mean of y, representing the relative amount of 
power in the theta range. 
Classification of cells 
Single units were classified as grid cells, head direction cells, spatially modulated 
non-grid cells, theta rhythmic cells, or interneurons.  Grid cells were further divided into 
conjunctive (additionally head direction modulated) and non-conjunctive grid cells.  To 
determine gridness, head direction, and spatial information thresholds, shuffling was 
performed as in Bonnevie et al. (2013), for gridness 3, MRL, and SI content, respectively.  
Briefly, the sequence of spikes from a given cell was time shifted along the rat’s path by 
a random interval between 20 s and 20 s minus session length, with the end wrapped to 
the beginning.  A single unit was deemed a given cell type if the value exceeded the 95th 
percentile of all shuffled permutations.  The thresholds for gridness3, MRL, and SI were 
0.2178, 0.3244, and 3.0176, respectively.  Cells not showing significant gridness, 
directionality, or SI content but were significantly theta rhythmic based on the measure 
described above, were deemed theta rhythmic cells.  Cells with firing rates greater than 
10 Hz were classified solely as putative interneurons (Savelli et al., 2008; Buetfering et 
al., 2014; Zheng et al., 2015).  Somewhat surprisingly, shuffling to determine the SI 
threshold resulted in a very high number, suggesting the ease to which cells can be 
classified as spatially modulated, considering a common threshold used is 0.5, regardless 
of whether the cell’s firing is based on actual spiking or shuffled data.  Given this, and 
that few cells could be classified as spatially modulated, analyses were limited to grid 
cells, HD cells, theta rhythmic cells, and interneurons. 
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Data exclusion 
 If an animal did not cover at least 80% of the total number of position bins (3.6 
cm x 3.6 cm) in the environment in the first 20 minutes of the recording session (length 
of most recordings) immediately following drug administration, that set of experiments 
were excluded from analyses (Bjerknes et al., 2014).  Histology was used to verify 
recording tracks to ensure they were positioned to record from the MEC area; in one 
animal the recording drive was positioned too anteriorly and data from that animal were 
excluded.  Single units were used for analyses if they were stable enough to be recorded 
across the first three recording sessions (Baseline, post-Drug/Vehicle administration, and 
3-6 hour recovery), otherwise data for that cell were excluded and not analyzed. 
Statistical tests of significance 
All comparisons between baseline and other conditions used a Bonferroni 
correction for multiple comparisons with an alpha value of 0.05.  This resulted in a p-
value of 0.0016 for both LFP and single unit tests (0.05/(4*4*2)) using an ANCOVA or 
repeated measures ANOVA, a p-value of 0.025 (0.05/2) for post-hoc t-tests, and a p-
value of 0.05 for median speed tests. 
For single unit analyses, a repeated measures ANOVA was performed for 
different measures (e.g. firing rate) to look at potential changes between baseline and 
after drug/vehicle administration, and tested for differences in the amount of change that 
occurred between the two groups.  A significant result from this test suggests that the 
change that occurred from baseline to post-administration was different for the drug 
compared to the change that occurred after the vehicle.  A non-significant result from this 
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suggests that any change that might have occurred from baseline to post-administration 
for the drug was not significantly different from the potential change occurring after 
vehicle administration. 
If the repeated measures ANOVA yielded a statistically significant result then a 
post-hoc paired t-test was performed to test for changes in the measure from baseline to 
post-administration.  A significant result from this suggests that after administration, the 
given measure changed significantly.  A non-significant result implies that after 
administration, it cannot be rejected that the values are from the same distribution.  
For LFP analyses, ANCOVAs were performed to examine changes in the 
intercept and slope of the relationship between LFP theta frequency, amplitude, and 
power across running speeds.  Comparisons were made to vehicle, looking at potential 
differences in the change in the given measure from the baseline to second session (the 
recording following drug or vehicle administration).  If an ANCOVA result was 
significant, a post-hoc ANOVA was performed to test for drug effects on the slope and 
intercept. 
2.3. Results 
2.3.1. Systemic administration of 8-OH-DPAT: LFP 
Systemic administration of the 5-HT1A agonist, 8-OH-DPAT, produced changes 
in MEC theta frequency that resemble those reported in the literature for recordings in the 
hippocampus.  ANCOVAs were performed to examine changes in the intercept and slope 
of the relationship between LFP theta frequency, amplitude, and power across running 
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speeds.  Comparisons were made to vehicle, looking at potential differences in the 
change in the given measure from the baseline to second session (the recording following 
drug or vehicle administration).  If an ANCOVA result was significant, a post-hoc 
ANOVA was performed to test for drug effects on the slope and intercept. 
Systemic administration of 8-OH-DPAT reduced the intercept of the relationship 
between theta frequency and running speed compared to vehicle (F(1,66)=869.92, p<1e-
10) (Figure 2.1 A1-2).  There was a drug effect in that 8-OH-DPAT injection reduced the 
intercept from baseline (F(1,96)=73.09, p<1e-10).  Slope increased significantly more 
during the second session after vehicle administration compared to after drug 
(F(1,66)=11.31, p=0.0013) (Figure 2.1 A1-2).  When comparing the slope during baseline 
and after drug administration, no significant differences were seen (F(1,96)=0.39, 
p=0.53).   
Drug administration produced a significant decrease in theta amplitude across 
running speeds compared to vehicle when looking at the intercept (F(1,66)=92.25, p<1e-
10) but not slope (F(1,66)=1.66, p=0.2) (Figure 2.1 B1-2).  However, looking at the effect 
of 8-OH-DPAT injection on the intercept of the amplitude, it did not reach significance 
(F(1,96)=8.95, p=0.0035).   
No changes were seen in theta power across running speeds after 8-OH-DPAT 
injection in comparison to vehicle for intercept (F(1,66)=1.38, p=0.24) or slope 
(F(1,66)=0.58, p=0.45) (Figure 2.1 C1-2).   
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2.3.2. Systemic administration of 8-OH-DPAT: single units 
Repeated measures ANOVAs were performed to examine changes between 
baseline and the second recording session (following drug or vehicle administration), 
testing for differences in this change when comparing drug and vehicle.  If the repeated 
measures ANOVA was significant, a post-hoc paired t-test was performed to test for drug 
effects on the given measure from baseline to the post-administration second session. 
In brief, no significant differences were seen in single unit firing properties after 
8-OH-DPAT systemic injection, other than in the rhythmicity of firing of grid cells.  
After 8-OH-DPAT injection compared to vehicle administration, no significant 
differences were found in the change in firing rates from baseline to the second session 
for grid cells (F(1,13)=0.13, p=0.72), head direction cells (F(1,34)=0.004, p=0.95), theta 
rhythmic cells (F(1,9)=0.01, p=0.93), or interneurons (F(1,7)=0.30, p=0.60) (Figure 2.2).  
Comparing drug and vehicle groups, there were no significant differences in the 
change from baseline to the second session for MRL in HD cells (F(1,34)=1.81, p=0.19) 
(Figure 2.3, right) or for conjunctive cells (F(1,9)=0.03, p=0.87) (Figure 2.3, left).  
No differences were seen from baseline to second session between the groups for 
grid cells for gridness score (F(1,13)=0.10, p=0.76) (Figure 2.4, left) or for grid field 
distance (F(1,11)=0.63, p=0.44) (Figure 2.4, right).  
The change in SI between the two sessions when comparing the groups for grid 
cells did not reach significance (F(1,13)=5.13, p=0.04) (Figure 2.5, left).  Spatial 
correlations between baseline rate maps of grid cells compared to every other session 
were calculated.  Because the correlation of the baseline to itself is always 1, differences 
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in correlation to baseline between the drug or vehicle session were compared to the 3-6 
hour recovery session.  No difference in the change was seen in spatial correlation when 
comparing drug and vehicle (F(1,13)=1.07, p=0.32) (Figure 2.5, right).   Overall, median 
running speed was not affected by 8-OH-DPAT injection (t(6)=-1.50, p=0.19) or vehicle 
(t(2)=0.07, p=0.95) (Figure 2.6).   
There was a difference found in the change in grid cell intrinsic rhythmicity 
frequency (F(1,13)=18.17, p<9.24e-4) from baseline to second session when comparing 
the drug and vehicle groups (Figure 2.7, left).  A drug effect on intrinsic rhythmicity was 
found after 8-OH-DPAT injection (t(9)=-3.83, p=0.004) and not after vehicle (t(4)=2.33, 
p=0.08). 
No significant differences were found in the change between groups for theta 
index (F(1,13=0.01, p=0.92) from baseline to second session (Figure 2.7, right).   
2.3.3. MS infusion of 8-OH-DPAT: LFP 
MS infusion of 8-OH-DPAT produced largely similar results to systemic 
administration.  Namely, after drug infusion, the intercept of the relationship between 
LFP theta frequency across running speeds robustly decreased compared to vehicle 
(F(1,66)=54.53, p<3.34e-10) (Figure 2.8, A1-2).  This was true looking within the drug 
group as well, the intercept decreased from baseline after infusion of 8-OH-DPAT 
(F(1,96)=23.27, p<5.27e-6) (Figure 2.8, A1).  No differences were found in the change in 
slope between baseline and the second session, comparing drug and vehicle 
(F(1,66)=0.04, p=0.85) (Figure 2.8, A1-2).   
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The intercept of the amplitude of LFP theta across running speeds significantly 
decreased after drug administration in comparison to vehicle (F(1,66)=20.71, p<2.36e-5), 
whereas no difference was found in slope (F(1,66)=0.31, p=0.58) (Figure 2.8, B1-2).  
Within the drug group, the decrease from baseline after MS infusion was not significant 
(F(1,96)=3.68, p=0.06) (Figure 2.8, B1).   
Drug administration did not significantly change theta power across running 
speeds in comparison to vehicle for either intercept (F(1,66)=1.49, p=0.23) or slope 
(F(1,66)=0.21, p=0.64) (Figure 2.8, C1-2).   
2.3.4. MS infusion of 8-OH-DPAT: single units 
In brief, no significant differences were seen in single unit firing properties after 
MS infusion of 8-OH-DPAT.  After 8-OH-DPAT infusion compared to vehicle infusion, 
no significant differences were found in the change in mean firing rates across cells from 
baseline for grid cells (F(1,12)=2.27, p=0.16), head direction cells (F(1,43)=0.03, p=0.86), 
theta rhythmic cells (F(1,23)=0.71, p=0.41), or interneurons (F(1,7)=0.71, p=0.41) 
(Figure 2.9).  
The change in MRL comparing drug and vehicle was not significant for 
conjunctive grid cells (F(1,8)=0.59, p=0.47) or HD cells (F(1,43)=0.41, p=0.53) (Figure 
2.10).  
There were no differences in the change of gridness scores (F(1,12)=0.12, p=0.73), 
field distance (F(1,8)=0.39, p=0.55), or SI (F(1,12)=0.25, p=0.63) in grid cells when 
comparing drug and vehicle (Figure 2.11 and Figure 2.12, left).  No difference was seen 
in the change of spatial correlation when comparing drug and vehicle spatial rate map 
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correlations to the baseline for the second session and the 3-6 hour recovery 
(F(1,12)=0.004, p=0.95) (Figure 2.12, right).   
Running speed of the animal did decrease significantly after 8-OH-DPAT 
infusion (t(9)=-4.03, p=0.003, non-Bonferroni corrected p-value threshold used) but not 
after vehicle infusion (t(1)=-6.58, p=0.1) (Figure 2.13). 
No significant differences in the change in intrinsic rhythmicity (F(1,12)=0.08, 
p=0.79) or theta index (F(1,12)=1.07, p=0.32) in grid cells from baseline to second 
session were found when comparing drug and vehicle groups (Figure 2.14). 
2.4. Discussion 
 These data show that systemic administration of a serotonergic anxiolytic 
decreased theta frequency found in the LFP of the MEC.  Specifically, it decreased the y-
intercept of the linear fit to the plot of theta frequency across a range of different running 
speeds.  These results strongly corroborate the previously reported effects of anxiolytics 
on hippocampal LFP theta (Wells et al., 2013), expanding detection to a new structure, 
the MEC.  A small decrease in the slope of this relationship as compared to the vehicle 
condition was also found, where it has been previously shown to increase with multiple 
same-day exposures to the environment (Jeewajee et al., 2008; Newman et al., 2013; 
Wells et al., 2013).  A decrease in slope from baseline after drug administration would 
suggest a potential increase in grid scale similar to what has been reported in rats exposed 
to novel environments (Barry et al., 2012) and in the hippocampus (Wells et al., 2013).  
However, when comparing the degree of decrease in slope to the previously reported 
effects of novelty, the decrease shown here appears to be much smaller.  This negligible 
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decrease in slope could explain why there were no significant changes in grid cell firing 
field distances after drug administration.  Even if a change did occur from this decrease it 
might have been too small to detect or not significant enough of a perturbation to the gain 
of the relationship between theta frequency and running speed to grossly affect grid scale. 
 To examine the role the MS might play in modulating theta frequency, MS 
infusions of 8-OH-DPAT were also performed.  The intercept of the relationship between 
theta frequency and running speed significantly decreased as compared to vehicle, similar 
to the systemic administration results.  While the magnitude of the decrease appeared to 
be less than systemic administration, dose effects were not systematically tested so it is 
unclear if infusing a larger amount could produce a similar sized decrease in frequency.  
This result suggests that the MS could be involved in the decrease in theta frequency seen 
after systemic injections of serotonergic anxiolytics, but whether it is required to produce 
the effects is beyond the scope of these experiments.   
 Similar to theta frequency, both systemic injection and MS infusion of 8-OH-
DPAT reduced the intercept of theta amplitude across running speeds.  Qualitatively, 
these findings mean theta oscillations in the LFP were slower and smaller in amplitude 
after either administration method of the serotonergic anxiolytic.  This could be achieved 
through the inhibitory effects of the neurotransmitter on postsynaptic receptors and 
autoreceptors.  Serotonin generally plays more of a modulatory role in the brain and as 
such activation of these receptors could produce less or lower probability of recruitment 
of neurons.  This could decrease the overall summed synaptic conductances producing 
theta rhythm in the LFP without eliminating it entirely, resulting in smaller amplitude 
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oscillations as fewer neurons are able to overcome the hyperpolarizing effect of 5-HT1A 
receptor activation.  The reduction in theta frequency produced by serotonergic 
anxiolytics has also been modeled in a septohippocampal system through increasing the 
time constant, thus slowing the oscillation (John et al., 2014). 
While median running speed was significantly lower after drug infusion, it is 
unlikely this affects the interpretation of the results.  For one, the manner of examining 
changes in LFP theta minimizes the effects of differences in running speed across 
sessions by looking within bounded speed windows.  Even given that a slower running 
speed would reduce theta frequency, the effect would be limited to lowering the average 
within a 2.5 cm/s bin, which is negligible.  Furthermore, not only was an effect on theta 
frequency and amplitude found for both systemic administration and MS infusion, the 
effect appeared larger after systemic administration, despite running speed only being 
significantly altered during infusion trials. 
No effects on theta power were seen after administration of the drug either via 
systemic injection or MS infusion when looking at power across running speeds.  This is 
in line with what was reported in the hippocampus after systemic injection of a similar 
anxiolytic when looking at theta power during median running speed-matched epochs 
(Wells et al., 2013).  The relatively flat or negative slope of theta power across running 
speeds also corroborates hippocampal data (Belchior et al., 2014). 
No changes were seen in the firing rates of any of the principal cell types or 
putative interneurons after systemic injection, similar to what was reported in principal 
cells in the hippocampus (Wells et al., 2013).  Furthermore, MS infusion did not elicit 
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change.  The only significant change across all single unit firing measures tested was in 
grid cell intrinsic rhythmicity of firing after systemic administration of 8-OH-DPAT.  
This finding highlights the resiliency of grid cells and other types of MEC cells in general 
to local perturbations in LFP frequency and the importance of the inputs the cells receive 
from other areas that pass on different information.  While the histology makes it difficult 
to pinpoint exactly what layer the grid cells were recorded from, due to the approach of 
the tetrodes traveling through deeper layers first, the multitude of conjunctive grid-by-
head-direction cells, and lack of phase precession, this suggests it is very likely that the 
recordings were from cells in deeper layers of the MEC (Sargolini et al., 2006; Hafting et 
al., 2008).  Further studies could examine the response of grid cells located more 
superficially, especially in terms of phase precession.  Given that the only single unit 
effect was on intrinsic rhythmicity, and none of the grid cells significantly phase 
precessed (data not shown), the decrease in the frequency of the rhythmic firing could 
reflect the maintenance of grid cell phase locking to LFP theta phase.  As theta frequency 
decreased in the LFP, the firing may have slowed slightly to maintain this locking to a 
constant phase, resulting in a decrease in the grid cell’s rhythmicity frequency.  It is 
possible that this slight decrease is too small to significantly affect mean firing rates 
across the entire session, and requires a larger decrease in LFP theta frequency than seen 
in the infusion data.  Future studies specifically analyzing theta phase locking and phase 
precession could clarify this possibility. 
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2.5. Tables 
Table 2.1. Literature review of 8-OH-DPAT doses given via intraperitoneal injection. 
Doses Task Effect Timing Citation 
12.5, 
25, 
100 
μg/kg 
Effects of IP injections in 
anesthetized rats on population 
responses in dentate gyrus 
evoked by perforant path 
stimulation. 
25 and 100 μg/kg 
produced substantial 
increase in amplitude 
of population spike, 
but not 12.5 μg/kg. 
Recorded 30 min post 
injection, when 
maximum was 
achieved (reached 
87.5% of peak increase 
at 15 minutes); higher 
dose (100 μg/kg) 
prolonged effect. 
Klancnik et 
al. (1989) 
100, 
200, 
500 
μg/kg 
Radial arm maze.  Examined 
working memory (defined as 
re-entry into arms previously 
chosen) and reference memory 
(entry into arms never baited). 
200 and 500 μg/kg 
produced deficits in 
working but not 
reference memory; 
100 μg/kg did not 
produce any effects. 
Behavioral testing 
began 15 minutes after 
injection. 
Isayama et 
al. (2001) 
30 
μg/kg 
Passive avoidance task. Passive avoidance 
performance was 
impaired when tested 
72 hours later. 
Task began 15 minutes 
post injection. 
Santucci & 
Shaw 
(2003) 
62 
μg/kg 
Pavlovian/instrumental 
autoshaping learning task. 
62 μg/kg increased 
conditioned response 
percent, suggested to 
be enhancement of 
memory 
consolidation. 
Drug administered 
after first autoshaping 
task; memory tested 24 
hours later (specifically 
testing memory 
consolidation). 
Manuel-
Apolinar & 
Meneses 
(2004) 
0.05, 
0.1, 1 
mg/kg 
Delayed non-matching-to-
position task. 
1 mg/kg decreased 
percent correct across 
delays and increased 
response bias.  No 
effect with lower 
doses.  May be more 
motivation related. 
Behavioral test began 
30 min post 
administration. 
Warburton 
et al. (1997) 
2.5 
mg/kg 
Measured reticular-elicited 
hippocampal rhythmical slow 
activity. 
Greatly reduced 
frequency of 
rhythmical slow 
activity. 
Max effects 45 min 
post injection (near 
maximum at 15). 
Coop et al. 
(1992) 
 
Table 2.2. Literature review of 8-OH-DPAT doses infused into the medial septum. 
Doses Task Effect Timing Citation 
1 or 4 
μg 
Assessed spatial 
learning using a 
water maze task 
and emotional 
learning in a 
passive avoidance 
task. 
Neither dose affected spatial learning, 4 μg 
dose impaired emotional learning.  
Retention was tested 24 hr after last training 
session. 
Training 
began 10 
min post 
infusion. 
Elvander-
Tottie et al. 
(2009) 
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4 μg Water maze.  
Elevated plus maze. 
Infusion before task prevented 
learning/retention of platform. When 
infused 2 hrs post acquisition (but not 
immediately, 1 hr, 4 hr, or 6 hrs) retention 
was disrupted.  Infusion pre-probe trial, 
retrieval not affected.  Did not affect 
elevated plus maze behavior (anxiety). 
10 min 
prior to 
testing. 
Koenig et 
al. (2008) 
0.5 or 4 
μg 
Water maze, 
injected before test 
phase. 
4 μg dose impaired performance, 0.5 μg 
dose showed trend but not significant. 
10 min 
prior to 
testing. 
Jeltsch et 
al. (2004) 
0.2, 
0.5, or 
2 μg 
Tested MS infusion 
on elevated plus 
maze. 
Only the intermediate dose (0.5 μg) had an 
effect; increased anxiety behavior as 
measured by entries into open arms (but 
locomotion overall also decreased). 
10 min 
prior to 
testing. 
De 
Almeida et 
al. (1998) 
0.1, 
0.25, 5 
and 10 
μg 
Shock probe test 
and elevated plus 
maze. 
5 and 10 μg decreased burying behavior in 
shock probe test.  No doses affected 
elevated plus maze behavior. 
-- Menard & 
Treit 
(1998) 
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2.6. Figures 
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Figure 2.1.  Systemic injection of 8-OH-DPAT reduces the intercept of theta frequency 
and amplitude.  
 
A. Effects of systemic injection (A1, red line) compared to baseline (black line) and 
recovery sessions (grey lines) on LFP theta frequency plotted across running speeds, and 
the same for vehicle (A2, blue line).  B, C.  Same as A but for theta amplitude and power, 
respectively. 
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8-OH-DPAT 
 
 
VEHICLE 
 
 
Figure 2.2.   Mean firing rate for grid cells, HD cells, theta rhythmic cells, and 
interneurons across sessions after systemic administration of 8-OH-DPAT. 
 
No drug effects on mean firing rate were seen across multiple cell types. 
Effects of systemic injection of 8-OH-DPAT (top) and vehicle (bottom) on mean firing 
rate of grid cells, HD cells, theta rhythmic cells, and interneurons.  Each cell recorded 
across sessions is marked by a single colored line.  The vertical black line represents the 
standard error of measurement. 
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VEHICLE 
 
 
Figure 2.3.   Mean resultant length of conjunctive and HD cells across sessions. 
 
Directionality of cell firing across sessions for conjunctive grid cells (left) and head 
direction cells (right) after systemic injection of 8-OH-DPAT (top) and vehicle (bottom).  
No drug effects on directionality of firing for conjunctive head by grid cells or HD cells 
were seen.  Each cell recorded across sessions is marked by a single colored line.  The 
vertical black line represents the standard error of measurement. 
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Figure 2.4.   Spatial periodicity and grid field distances were not affected by 8-OH-
DPAT systemic administration. 
 
Gridness score (left) and grid field distance (right) of grid cells after systemic injection of 
8-OH-DPAT (top) and vehicle (bottom).  Each cell recorded across sessions is marked by 
a single colored line.  The vertical black line represents the standard error of 
measurement. 
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Figure 2.5. Spatial information score and correlation of rate maps of grid cells 
maintained after drug and vehicle administration. 
 
Measures of spatial firing after systemic injection of 8-OH-DPAT (top) and vehicle 
(bottom) for spatial information (left) and spatial correlation of rate maps (right).  Each 
cell recorded across sessions is marked by a single colored line.  The vertical black line 
represents the standard error of measurement. 
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Figure 2.6. Median running speed (cm/s) across recording sessions. 
 
No significant changes in median running speed from baseline to the second recording 
session were seen after administration of 8-OH-DPAT systemic (top) or PBS (vehicle) 
systemic experiments (bottom).  Each session’s median speed is marked by a single 
colored line.  The vertical black line represents the standard error of measurement. 
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Figure 2.7.   A significant difference in intrinsic rhythmicity was found after 8-OH-
DPAT systemic injection. 
 
Firing rhythmicity (left) and theta index (right) for systemic injections of 8-OH-DPAT 
(top) and vehicle (bottom).  Each cell recorded across sessions is marked by a single 
colored line.  The vertical black line represents the standard error of measurement. 
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Figure 2.8.  MS infusion of 8-OH-DPAT reduces the intercept of theta frequency and 
amplitude.  
 
A. Effects of MS infusion (A1, red line) compared to baseline (black line) and recovery 
sessions (grey lines) on LFP theta frequency plotted across running speeds, and the same 
for vehicle (A2, blue line).  B, C.  Same as A but for theta amplitude and power, 
respectively. 
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Figure 2.9.   Mean firing rate for grid cells, HD cells, theta rhythmic cells, and 
interneurons across sessions after 8-OH-DPAT infusion and vehicle. 
 
No significant effects found from MS infusion of 8-OH-DPAT (top) and vehicle (bottom) 
on mean firing rate of grid cells, HD cells, theta rhythmic cells, and interneurons.  Each 
cell recorded across sessions is marked by a single colored line.  The vertical black line 
represents the standard error of measurement. 
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Figure 2.10.  Mean resultant length of conjunctive and HD cells across sessions. 
 
Directionality of cell firing across sessions for conjunctive grid cells and head direction 
cells after MS infusion of 8-OH-DPAT (top) and PBS (bottom).  Each cell recorded 
across sessions is marked by a single colored line.  The vertical black line represents the 
standard error of measurement. 
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Figure 2.11.  Spatial periodicity and grid field distances were unaffected by 8-OH-DPAT 
infusion. 
 
Gridness score and grid field distance of grid cells after MS infusion of 8-OH-DPAT 
(top) and vehicle (bottom).  Each cell recorded across sessions is marked by a single 
colored line.  The vertical black line represents the standard error of measurement. 
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Figure 2.12. Spatial information score and correlation of rate maps of grid cells 
maintained after 8-OH-DPAT and vehicle infusion. 
 
Measures of spatial firing after MS infusion of 8-OH-DPAT (top) and vehicle (bottom) 
for spatial information (left) and spatial correlation of rate maps (right).  Each cell 
recorded across sessions is marked by a single colored line.  The vertical black line 
represents the standard error of measurement. 
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Figure 2.13.  Median running speed (cm/s) across recording sessions. 
 
Median running speed (cm/s) for 8-OH-DPAT infusion experiments (top) and PBS 
(vehicle) infusion experiments (bottom). There was a significant decrease in median 
running speed after 8-OH-DPAT infusion.  Each session’s median speed is marked by a 
single colored line.  The vertical black line represents the standard error of measurement. 
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Figure 2.14.  No significant differences seen in intrinsic firing rhythmicity after 8-OH-
DPAT or vehicle infusion. 
 
Firing rhythmicity (left) and theta index (right) for MS infusions of 8-OH-DPAT (top) 
and vehicle (bottom).  Each cell recorded across sessions is marked by a single colored 
line.  The vertical black line represents the standard error of measurement. 
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CHAPTER 3: Effects of systemic administration and MS infusion of a 
benzodiazepine on MEC activity2 
 
 
 
 
 
 
 
 
 
 
2Monaghan, CK, Chapman IV, GW, Hasselmo, ME.  In prep. 
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3.1. Introduction 
 Benzodiazepines (BDZs) are classic anxiolytics that have been well studied since 
their discovery decades ago.  Similar to serotonergic anxiolytics, BDZs reduce 
hippocampal theta frequency in both awake, behaving animals and via reticular formation 
stimulation.  However, despite the entorhinal cortex providing Type I theta to the 
hippocampus and the medial septum (MS) pacemaking both regions, little research has 
focused on the effects of BDZs on these areas.  This is especially of interest as grid cells, 
neurons that are spatially modulated and periodic, are found in the medial entorhinal 
cortex (MEC) and have been correlated with theta rhythm in many ways (Giocomo et al., 
2007; Jeewajee et al., 2008; Barry et al., 2012).  Furthermore, input from the MS is 
necessary for maintaining the spatially periodic firing of grid cells and reduction of this is 
correlated with a disruption in theta (Brandon et al., 2011; Koenig et al., 2011).  Grid 
scale has been correlated with theta frequency in a number of different ways and 
anxiolytics offer the opportunity to observe the effects of manipulating just the frequency 
without disrupting theta oscillations completely. 
3.1.1. Dense GABAergic innervation throughout MS and MEC influences activity 
GABA is the major inhibitory neurotransmitter and therefore GABA receptors are 
found ubiquitously throughout the brain.  BDZs, such as diazepam, are positive allosteric 
modulators of GABA-A receptors and act by binding to the BDZ site, enhancing the 
effects of GABA (i.e. generally increasing chloride influx and pushing the cell toward the 
Nernst potential for chloride which is below the firing threshold) (Tan et al., 2011).  The 
BDZ sites are found on GABA-A receptors between the alpha and gamma subunits 
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making up the receptor complex, and BDZs can affect different receptors made up of 
multiple subunit combinations, with only alpha4 and alpha6 isoforms being BDZ 
insensitive (Gao et al., 1995; Tan et al., 2011).  One of the most common GABA-A 
receptor combinations accounts for over 40% of GABA-A receptors in the brain and is 
sensitive to BDZs (Gao et al., 1995).  BDZ sensitive GABA-A receptors are present on 
both GABAergic and cholinergic neurons in the MS (Gao et al., 1995), and throughout 
cells in the MEC, suggesting BDZs could affect activity in these areas directly. 
MS infusion of the GABA-A agonist muscimol severely disrupts both theta 
rhythm in the MEC and the spatial selectivity of grid cells (Mizumori et al., 1989; 
Brandon et al., 2011).  However, since muscimol acts directly on GABA sites (as 
opposed to diazepam which has a positive modulatory effect through the BDZ site) it can 
still produce inhibition in cells without an afferent neuron releasing GABA (Gao et al., 
1995).  This could explain why theta power is nearly completely eliminated with 
muscimol infusions, whereas theta frequency and power are merely reduced with 
diazepam (Caudarella et al., 1987; Scheffzük et al., 2013). 
3.1.2 Models provide testable predictions involving administration of benzodiazepines 
Oscillatory interference models (OIMs) use interacting theta frequency 
oscillations to generate the spatially periodic firing of grid cells.  Slight differences in 
theta frequency, as is seen in the subthreshold membrane potential oscillations recorded 
in layer II MEC stellate cells in vitro (Giocomo et al., 2007) and in the frequency of the 
rhythmicity of grid cell firing (Jeewajee et al., 2008), are hypothesized to be involved 
with the grid field size and spacing increase seen in progressively more ventrally 
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recorded grid cells in the MEC (Brun et al., 2008).  Specifically, Burgess (2008) 
suggested that anxiolytics reduce the intercept, and not the slope, of the relationship 
between theta frequency and running speed.  Therefore, while the mean theta frequency 
would decrease, grid scale would not be affected by anxiolytic administration. 
The mechanisms underlying BDZ induced decreases in theta frequency are not 
well understood, and it is not known whether effects are mediated through the MS, which 
is necessary for theta rhythm in the MEC.  Infusing a BDZ into the MS can test the 
involvement of this structure, along with a model prediction by John et al. (2014).  In a 
septo-hippocampal model of the experimental results of anxiolytic effects on 
hippocampal theta shown by Wells et al. (2013), they predicted that introduction of BDZs 
into this system would be unable to produce a measurable effect on theta frequency.  By 
comparing MEC recordings just before and following MS infusion of a BDZ to systemic 
experiments, this prediction can also be explicitly tested. 
3.2. Materials and Methods 
3.2.1. Subjects 
Male Long-Evans rats (Charles River Laboratories) weighing between 350-450 
grams at surgery were used for these studies.  All experimental procedures were approved 
by the Institutional Animal Care and Use Committee for the Charles River Campus at 
Boston University.  Rats were housed individually in plexiglass cages, maintained on a 
12-hour light/12-hour dark cycle (testing always occurred during the light cycle), and 
were maintained at ~85% of their ad libitum weight.  Prior to surgery, rats were 
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habituated to the experimenter and testing room.  The animals were trained to forage in 
an open field environment (1 m by 1.5 m) for pieces of Froot Loops (Kellogg’s).  One 
wall of the otherwise black painted environment was white to provide stable landmark 
information; cues surrounding the environment were present to provide distal information 
as well. 
3.2.2. Implant 
Rats were implanted with recording drives housing up to 16 individually 
moveable tetrodes (four 12.7 μm nichrome wires spun together) and 4 reference tetrodes, 
aimed at the MEC.  Tetrodes were gold plated to bring down the impedance to <150 
kOhm.  The exit of the drive was angled at ~25 degrees in the posterior direction in order 
to implant just anterior of the transverse sinus. 
3.2.3. Surgery 
Rats were anesthetized with isoflurane and given an injection of a 
ketamine/xylazine/acepromazine cocktail and buprenorphine; depth of anesthesia was 
monitored at least every 15 minutes by checking breathing and confirming lack of 
response to a toe pinch.  An injection of atropine was given to prevent fluid buildup in the 
lungs.  After the initial incision, the skull area was cleared of fascia and approximately 10 
holes were drilled to attach anchor screws into the skull; 1-2 ground screws were placed 
over the cerebellum.  Two craniotomies were performed: one to implant a drug delivery 
cannula (from Bregma: 0.5 mm anterior, 3.0 mm lateral; implanted at 25 degrees 
medially, lowered 6.0 mm from brain surface) and the second as the implant site (left 
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hemisphere; most lateral and posterior corner grazes where the left bone ridge and 
lambda suture meet).  The implant was secured in place using Kwik-Sil and dental acrylic.  
Tetrodes were lowered 2-3 mm from the dorsal surface at surgery.  Animals were 
allowed one week to fully recover after surgery before experiments began. 
3.2.4. Neural recordings 
Animals were tested daily in the open field during recordings to search for grid 
cells, conjunctive grid-by-head-direction cells, border cells, and theta rhythmic cells.  
Once theta rhythmic cells and theta oscillations in the LFP were recorded, tetrodes were 
lowered a maximum of ~35 μm/day; experiments were never done on days tetrodes were 
turned in order to maximize the likelihood of recording the same cells across sessions.  
Neural signals were preamplified by unity-gain operational amplifiers located on the head 
of the animal.  Signals were linked to digital amplifiers and amplified (5,000-20,000X) 
and bandpass filtered (1-500 Hz) by the 64-channel Cheetah Digital Lynx acquisition 
system (Neuralynx Corp., Bozeman, MT).  When a signal crossed threshold all four 
channels of the tetrode were digitized at 32 kHz and recorded.  Position, head direction, 
and velocity data were calculated from a red (front) and green (back) diode positioned on 
the recording head stage and sampled at 30 Hz.  Position was determined as the centroid 
of the diodes.  LFP activity was collected at 32 kHz and downsampled to 508 Hz.  LFP 
traces obtained from the MEC were recorded from a single lead of a tetrode and 
referenced to the animal ground or to a cortical electrode that did not show theta 
oscillations when referenced to ground. 
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3.2.5. Histology 
When possible, final tetrode positions were marked before sacrificing the animal 
by passing current through tetrodes that had recorded grid cells.  Animals were overdosed 
with isoflurane and perfused intracardially with saline followed by 4% paraformaldehyde.  
Brains were extracted and stored in 4% paraformaldehyde at 6 degrees C for at least 24 
hours.  Approximately 72 hours before slicing, brains were transferred into a 30% 
sucrose solution.  The brain was cut to separate the MS and MEC portions; the MEC was 
sectioned along the sagittal plane to visualize tetrode tracks, while the MS was sliced 
along the coronal plane to confirm cannula placement.  Sections were mounted on 
gelatin-subbed glass slides and stained with cresyl violet. 
3.2.6. Experimental design 
One to two 20-minute pre-drug recording sessions were performed prior to drug 
injection or infusion.  After drug administration, recording sessions were performed up to 
45 minutes in duration to ensure adequate coverage of the environment.  This session 
began within 10 minutes following diazepam infusion, within 15 minutes of muscimol 
infusion, and at 30 minutes post diazepam injection.  A twenty-minute recovery session 
was recorded 3-6 hours post-drug administration and 24 hours later, to confirm return to 
normal activity.  Multiple experiments, including administration of different types of 
drugs, were performed in a rat for as long as a given grid cell could be well-isolated, 
however there was a minimum of 48 hours between all drug and vehicle administrations.  
When single units of interest could no longer be isolated, tetrodes were moved down and 
screening for cells of interest began again. 
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3.2.7. Drugs and drug administration 
Drugs were administered either systemically through intraperitoneal injection or 
intracranially into the MS via the implanted guide cannula.  Prior to an infusion, the 
dummy cannula was removed to allow access to the guide cannula.  An injector cannula 
(33 gauge), extending 1 mm beyond the guide cannula, was filled with the drug or 
vehicle and lowered through the guide cannula and into the MS.  A microinfusion pump 
infused 0.5 μL of the solution at a rate of 0.125 μL/min.  The injector cannula was left 
inserted for two minutes after the infusion to allow the drug to diffuse throughout the 
tissue.  The injector cannula was then removed and replaced with a sterilized dummy 
cannula. 
Volume-matched vehicle controls were performed for both systemic injections (1 
mL/kg) and infusions (0.5 μL).  The BDZ diazepam (Sigma) was mixed in DMSO to 
make a concentration of 1.0 mg/mL and administered at 1.0 mg/kg systemically or 
infused between 5-30 μg.  At this point, not enough DMSO (vehicle) infusion 
experiments had been performed to compare drug effects against so PBS was used for 
statistical testing for the time being.  It is worth nothing that in the literature, lateral 
septum infusions of DMSO plus Cremophor and saline do not produce any behavioral 
effects (Stemmelin et al., 2005).  Infusion of DMSO into the medial septum, 
hippocampus unilaterally or bilaterally, or intraventricularly did not have any effects on 
theta rhythm in the LFP, including looking at power and frequency (Leung and Shen, 
2004; Sharifzadeh et al., 2005; Tronson et al., 2009).  
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Before commencing the first infusion experiment in a rat, a muscimol infusion 
(0.5 μL of 0.5 μg/μL) was performed once a grid cell was recorded and/or when theta 
oscillations were present in the LFP to confirm loss of theta power and grid cell spatial 
periodicity (when grid cells were being recorded) in order to verify correct cannula 
placement.  If spatial periodicity and theta power were not disrupted, an injector cannula 
with a 2mm projection was tried, at least 48 hours later.  If this was not successful, the rat 
was not used for collecting infusion data. 
Diazepam systemic  
Diazepam has been used widely in the literature and a small selection of 
representative doses can be found in Table 3.1.  In this work, 1 mg/kg was administered 
as it was commonly found in the literature and did not greatly affect ambulation in most 
cases.  In most reported cases, diazepam injection preceded experimental testing by 30 
minutes; the same was done in these experiments as well. 
Diazepam infusion 
Literature review only yielded two groups reporting effects of infusing diazepam 
into the MS (Table 3.2).  The amounts reported were quite a bit lower than what has been 
reported when infused into other areas of the brain (Table 3.3).  Several infusion amounts 
were tested to help ensure any negative result was not due to insufficient concentration 
and included 2.5, 5, 10, and 15 μg.  Experimental testing was performed ranging from 
immediately after diazepam infusion to 25 minutes post.  Most recordings for this work 
were performed approximately 10 minutes after diazepam infusion. 
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3.2.8. Analyses 
Cluster cutting across sessions 
After the completion of each recording session, single units were isolated using 
cluster cutting software (Offline Sorter, Plexon Inc.).  Single units were distinguished 
using peak amplitude and principal components for each waveform.  Stability of units 
was confirmed by tracking waveform profiles across the four leads of the tetrode and 
cluster position across recording sessions, comparing to the baseline session.  
Measurement of theta rhythm and running speed 
LFP activity was collected at 32 kHz and downsampled to 508 Hz.  Downsampled 
LFP was filtered using a second order butterworth bandpass filter with cutoff frequencies 
of 6-10 Hz for theta band.  Phase was estimated using the angle of the Hilbert transform 
of the filtered signal and instantaneous amplitude was estimated as the amplitude of the 
Hilbert transform.  The LFP channel used for analyses was chosen on an animal-by-
animal basis for each set of four recording sessions based on spectral properties from the 
baseline recording (Brandon et al., 2013).  For each channel the spectrum of LFP power 
was found, the peak within theta range determined, and divided by the mean signal, 
giving the relative power within the theta band.  The LFP channel was then chosen as the 
channel with maximum theta to noise ratio for each rat's baseline session.  Theta 
frequency, amplitude, and power were calculated for 2.5 cm/s running speed bins and 
plotted from 5-30 cm/s.  Each rat's LFP signal was normalized to aid comparison between 
animals per Wells et al. (2013).  In brief, for each measure (frequency, amplitude, and 
power), the overall mean across all animals during baseline was calculated.  A 
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normalization factor was determined on an animal-by-animal basis as the mean 
difference in the animal’s baseline signal from the population mean.  This normalization 
factor was applied across all sessions for each animal, giving a normalized signal.  This 
method accounts for a mean difference, but not speed modulated difference, in theta 
measures between animals. 
Measurement of single unit properties 
Spatial rate maps were constructed for a given unit by taking the number of spikes 
in 3.6 cm by 3.6 cm spatial bins and dividing by the amount of time spent in that bin.  
Rate maps were smoothed using a 5x5 bin pseudo-Gaussian kernel with a one-pixel 
standard deviation.  The spatial periodicity of grid cells was quantified with a “gridness” 
score and computed from the spatial autocorrelation of the smoothed rate maps.  For the 
gridness score calculated, “gridness 3,” the center peak was removed from the 
autocorrelation and if present, the six surrounding peaks found and cut out to make a 
donut.  If the grid shape was elliptical, it was distorted to create a circle.  The correlation 
was calculated for each 3 degree rotation of the donut to itself.  The gridness score is the 
difference between the correlation at the minimum peak of 60 or 120 degrees and the 
maximum trough at 30, 90, or 150 degrees.  The grid field distance was determined from 
the spatial autocorrelation by calculating the average distance between the middle and six 
surrounding peaks, checked manually to ensure the proper fields were being detected and 
measured.   
Head direction firing properties of units were calculated by constructing a polar 
histogram of firing rates by head direction.  Spikes were put into bins of 6 degrees and 
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divided by the amount of time spent facing that direction.  The mean resultant length 
(MRL) of the directionality of spiking was then calculated.   
The spatial information (SI) score reflects the degree to which a cell’s spiking can 
be used to predict the animal’s location.  It was calculated as in Cacucci et al. (2007) and 
expressed in bits/spike.  Correlation of the spatial rate maps for cells were calculated by 
finding the Pearson’s correlation coefficient between the baseline rate map and the 
following sessions for a given cell.   
Spike time autocorrelograms were created with time bins of 10 ms and 
normalized and clipped to the peak in the theta range (6-10 Hz).  Autocorrelograms were 
then fit with the equation: 
y(t) =[a*(cos(ω*t)+1)+b]*exp(-|x|/τ1)+c*exp(-t2 /τ22 )) 
Where y(t) is the normalized autocorrelogram value, t is the time lag, a is an 
amplitude of rhythmicity, τ1 and τ2 are fall off constants, b and c are coefficients for theta 
rhythmicity and theta skipping, and ω is the intrinsic frequency of the cell.  The theta 
index was then defined as (a+b) over the mean of y, representing the relative amount of 
power in the theta range. 
Classification of cells 
Single units were classified as grid cells, head direction cells, spatially modulated 
non-grid cells, theta rhythmic cells, or interneurons.  Grid cells were further divided into 
conjunctive (additionally head direction modulated) and non-conjunctive grid cells.  To 
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determine gridness, head direction, and spatial information thresholds, shuffling was 
performed as in Bonnevie et al. (2013), for gridness 3, MRL, and SI content, respectively.  
Briefly, the sequence of spikes from a given cell was time shifted along the rat’s path by 
a random interval between 20 s and 20 s minus session length, with the end wrapped to 
the beginning.  A single unit was deemed a given cell type if the value exceeded the 95th 
percentile of all shuffled permutations.  The thresholds for gridness3, MRL, and SI were 
0.1902, 0.1586, and 3.2816, respectively.  Cells not showing significant gridness, 
directionality, or SI content but were significantly theta rhythmic based on the measure 
described above, were deemed theta rhythmic cells.  Cells with firing rates greater than 
10 Hz were classified solely as putative interneurons (Savelli et al., 2008; Buetfering et 
al., 2014; Zheng et al., 2015).  Somewhat surprisingly, shuffling to determine the SI 
threshold resulted in a very high number, suggesting the ease to which cells can be 
classified as spatially modulated, considering a common threshold used is 0.5, regardless 
of whether the cell’s firing is based on actual spiking or shuffled data.  Given this, and 
that few cells could be classified as spatially modulated, analyses were limited to grid 
cells, HD cells, theta rhythmic cells, and interneurons. 
Data exclusion 
 If an animal did not cover at least 80% of the total number of position bins (3.6 
cm x 3.6 cm) in the environment in the first 20 minutes of the recording session (length 
of most recordings) during the session immediately following drug administration, that 
set of experiments were excluded from analyses (Bjerknes et al., 2014).  Histology was 
used to verify recording tracks to ensure they were positioned to record from the MEC 
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area; in one animal the recording drive was positioned too anteriorly and data from that 
animal were excluded.  Single units were used for analyses if they were stable enough to 
be recorded across the first three recording sessions (Baseline, post-Drug/Vehicle 
administration, and 3-6 hour recovery), otherwise data for that cell were excluded and not 
analyzed. 
Statistical tests of significance 
All comparisons between baseline and other conditions used a Bonferroni 
correction for multiple comparisons with an alpha value of 0.05.  This resulted in a p-
value of 0.0016 for both LFP and single unit tests (0.05/(4*4*2) using an ANCOVA or 
repeated measures ANOVA, a p-value of 0.025 (0.05/2) for post-hoc t-tests, and a p-
value of 0.05 for median speed tests. 
For single unit analyses, a repeated measures ANOVA was performed for 
different measures (e.g. firing rate) to look at potential changes between baseline and 
after drug/vehicle administration, and tested for differences in the amount of change that 
occurred between the two groups.  A significant result from this test suggests that the 
change that occurred from baseline to post-administration was different for the drug 
compared to the change that occurred after the vehicle.  A non-significant result from this 
suggests that any change that might have occurred from baseline to post-administration 
for the drug was not significantly different from the potential change occurring after 
vehicle administration. 
If the repeated measures ANOVA yielded a statistically significant result then a 
post-hoc paired t-test was performed to test for changes in the measure from baseline to 
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post-administration.  A significant result from this suggests that after administration, the 
given measure changed significantly.  A non-significant result implies that after 
administration, it cannot be rejected that the values are from the same distribution.  
For LFP analyses, ANCOVAs were performed to examine changes in the 
intercept and slope of the relationship between LFP theta frequency, amplitude, and 
power across running speeds.  Comparisons were made to vehicle, looking at potential 
differences in the change in the given measure from the baseline to second session (the 
recording following drug or vehicle administration).  If an ANCOVA result was 
significant, a post-hoc ANOVA was performed to test for drug effects on the slope and 
intercept. 
3.3. Results 
3.3.1. Systemic administration of diazepam: LFP 
Systemic administration of diazepam produced significant effects on theta 
frequency across a range of running speeds, similar to what has been reported in the 
hippocampus.  ANCOVAs were performed to examine changes in the intercept and slope 
of the relationship between LFP theta frequency, amplitude, and power across running 
speeds.  Comparisons were made to vehicle, looking at differences in the change in the 
given measure from the baseline to second session (the recording following drug or 
vehicle administration).  If an ANCOVA result was significant, a post-hoc ANOVA was 
performed to test for drug effects on the slope and intercept. 
 
 
 
73 
After drug administration, the intercept of the relationship between theta 
frequency and running speed decreased from baseline compared to vehicle 
(F(1,66)=43.11, p<9.51e-9) (Figure 3.1, A1-2).  This decrease was significant when 
looking at just the effect of drug from baseline as well (F(1,76)=88.19, p<1e-10) (Figure 
3.1, A1).  There were no significant differences found in the change in slope after drug 
administration compared to vehicle (F(1,66)=0.46, p=0.5) (Figure 3.1, A1-2).   
Compared to vehicle, the change in intercept of theta amplitude across running 
speeds decreased after drug administration (F(1,66)=29.02, p<1.03e-6) while the 
difference in slope was not significantly different (F(1,66)=0.02, p=0.88) (Figure 3.1, B1-
2).  The decrease in the intercept was not significant when only looking at the change 
from baseline after diazepam injection (F(1,76)=0.33, p=0.57) (Figure 3.1, B1).   
The intercept of theta power across running speeds was reduced after drug 
administration in comparison to vehicle (F(1,66)=17.15, p<1.00e-4) (Figure 3.1, C1-2).  
When looking at just the drug effect on the intercept of power from baseline, this was not 
significant (F(1,76)=3.29, p=0.07) (Figure 3.1, C1).  No significant differences were seen 
in the changes in slope of theta power across running speeds when comparing drug and 
vehicle administration (F(1,66)=0.79, p=0.38) (Figure 3.1, C1-2). 
3.3.2. Systemic administration of diazepam: single units 
Repeated measures ANOVAs were performed to examine changes between 
baseline and the second recording session (following drug or vehicle administration), 
testing for differences in this change when comparing drug and vehicle.  If the repeated 
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measures ANOVA was significant, a post-hoc paired t-test was performed to test for drug 
effects on the given measure from baseline to the post-administration second session. 
In brief, no significant differences were seen in single unit firing properties after 
systemic administration of diazepam.  After drug administration compared to vehicle 
administration, no differences were found in the change in mean firing rate between drug 
and vehicle for grid cells (F(1,12)=1.42, p=0.26), head direction cells (F(1,27)=2.06, 
p=0.16), theta rhythmic cells (F(1,20)=0.21, p=0.65), or interneurons (F(1,5)=6.48, 
p=0.051) (Figure 3.2).  
No differences were found in the change between baseline and the second session 
in MRL for conjunctive cells (F(1,7)=0.23, p=0.65) or HD cells (F(1,27)=8.10, p=0.008) 
(Figure 3.3).  
The differences in the change between drug and vehicle for gridness 
(F(1,12)=0.63, p=0.44) and grid field distance (F(1,7)=6.11, p=0.04) did not reach 
significance (Figure 3.4).  Although qualitatively it looks like approximately half of the 
grid cells dropped in gridness score, most of those grid scores stayed below the threshold 
the remaining sessions.  The rate maps and spatial autocorrelograms for all of the 
recorded grid cells can be seen in Figure 3.5.   
There was no significant difference in the change seen in SI for grid cells when 
comparing drug and vehicle groups (F(1,12)=2.84, p=0.12) (Figure 3.6, left).  Because 
the correlation of the baseline to itself is always 1, differences in spatial correlation of 
rate maps to baseline between the drug or vehicle session were compared to the 3-6 hour 
recovery session.  No significant differences were seen when looking at the change in 
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spatial correlation when comparing drug and vehicle (F(1,12)=0.78, p=0.39) (Figure 3.6, 
right).  Overall, systemic injection of diazepam did not have a significant effect on 
median running speed (t(4)=-1.88, p=0.13), nor did vehicle injection (t(3)=-0.73, p=0.52) 
(Figure 3.7).   
No differences were seen in grid cells from baseline to the second session when 
comparing drug and vehicle groups in the change in intrinsic rhythmicity (F(1,12)=1.03, 
p=0.33) (Figure 3.8, left) or in theta index (F(1,12)=0.03, p=0.86).   
3.3.3. MS infusion of diazepam: LFP 
Across doses, MS infusion of diazepam did not produce any significant 
differences in the change in theta frequency across running speeds when compared to 
PBS vehicle infusion for either intercept (F(1,56)=0.07, p=0.79) or slope (F(1,56)=1.21, 
p=0.28) (Figure 3.9, A1-2), despite infusions of muscimol and the serotonergic agonist, 
8-OH-DPAT producing effects within the same animals (Figure 3.10).   
No significant differences between drug and vehicle were found in the change in 
amplitude of this relationship in the intercept (F(1,56)=4.43, p=0.04) or the slope 
(F(1,56)=3.33, p=0.07) (Figure 3.9, B1-2).   
No significant differences were found in the change of theta power across running 
speeds comparing drug and vehicle for intercept (F(1,56)=2.32, p=0.13) or slope 
(F(1,56)=0.001, p=0.97) (Figure 3.9, C1-2). 
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3.3.4. MS infusion of diazepam: single units 
In brief, no significant differences were seen in single unit firing properties after 
MS infusion of diazepam.  After drug infusion compared to PBS infusion, there were no 
significant differences seen in the change in firing rates for grid cells (F(1,11)=1.63, 
p=0.23), head direction cells (F(1,26)=0.01, p=0.91), theta rhythmic cells (F(1,26)=0.01, 
p=0.92), or interneurons (F(1,7)=9.75e-4, p=0.98) when comparing changes seen in drug 
and vehicle groups (Figure 3.11).  
No significant differences in changes between drug and vehicle groups in the 
MRL for HD cells (F(1,26)=1.81, p=0.19) (Figure 3.12, right) or conjunctive cells 
(F(1,4)=0.05, p=0.83) (Figure 3.12, left) were found.  
Testing for differences in changes after infusion of diazepam or vehicle when 
comparing the two was not significant for gridness score (F(1,11)=0.07, p=0.80) or grid 
field distance (F(1,7)=0.12, p=0.74) (Figure 3.13).  
No difference was seen in the change in SI between the two groups from baseline 
to the second session for grid cells (F(1,11)=0.82, p=0.39) (Figure 3.14, left). No 
significant difference emerged in the change of spatial correlation of spatial rate maps to 
baseline when comparing drug and vehicle effects between post-drug administration and 
the 3-6 hour recovery session (F(1,11)=0.25, p=0.62) (Figure 3.14, right).  MS infusion 
of diazepam significantly decreased median running speed from baseline to post-infusion 
sessions (t(6)=-6.43, p<6.71e-4) while PBS vehicle infusion did not (t(1)=-6.58, p=0.1) 
(Figure 3.15).   
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No changes were seen from baseline to the second session when comparing drug 
and vehicle groups for grid cell intrinsic firing rhythmicity (F(1,11)=1.94, p=0.19) or 
theta index (F(1,11)=1.68, p=0.22) (Figure 3.16). 
3.4. Discussion 
 In our results, the systemic administration of a benzodiazepine decreased theta 
frequency.  Specifically, it decreased the y-intercept of the linear fit to the plot of theta 
frequency over different running speeds.  Furthermore, systemic administration also 
decreased the intercept of the amplitude of theta oscillations across running speeds, 
suggesting theta rhythm became slower and smaller after systemic administration of 
diazepam.  The systemic results from these experiments strongly corroborate the reported 
effects of anxiolytics on hippocampal LFP theta frequency (Wells et al., 2013), 
expanding detection to a new structure, the MEC.   
MS infusion of diazepam did not produce any changes in MEC theta frequency, 
despite infusions of muscimol, a GABA-A agonist, disrupting theta oscillations in the 
same animals, as in previous reports (Mizumori et al., 1989; Brandon et al., 2011).  This 
suggests that despite the MS being necessary for theta oscillations in both the MEC and 
hippocampus, the actions leading to a decrease in theta frequency in these areas by BDZs 
must be exerted outside the MS.  In a septo-hippocampal model examining the effects of 
anxiolytic drugs on this circuit, it was suggested that increasing the maximal synaptic 
conductance of GABA-A receptors in this circuit had a negligible effect on mean theta 
frequency, predicting that introduction of BDZs into a septo-hippocampal circuit would 
not affect theta frequency (John et al., 2014).  The septo-entorhinal circuit shares many 
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similarities with the septo-hippocampal circuit, including decreases in theta frequency 
after systemic administration of anxiolytics and if the John et al. (2014) prediction is 
extended to involve the MEC as well, this would lend support.  John et al. (2014) suggest 
that the BDZ effect on theta frequency is mediated through medial hypothalamic sites, 
given that infusions of CDP into the medial supramammillary nucleus produce anxiolytic 
effects similar to systemic administration and reduce hippocampal theta frequency 
(Woodnorth and McNaughton, 2002; John et al., 2014).  Future experiments involving 
BDZ infusions into the medial supramammillary nucleus while recording activity in the 
MEC could confirm this, but are beyond the scope of this work. 
While median running speed was significantly lower after drug infusion, it is 
unlikely this affects the interpretation of the results.  For one, the manner of examining 
changes in LFP theta minimizes the effects of differences in running speed across 
sessions by looking within bounded speed windows.  Even given that a slower running 
speed would reduce theta frequency, the effect would be limited to lowering the average 
within a 2.5 cm/s bin, which is negligible.  Furthermore, a drug effect on theta frequency 
was only found after systemic administration and not MS infusion, despite running speed 
being significantly altered during infusion trials. 
Examining theta power across running speeds suggested a slight decrease in 
power through a change in the intercept and not the slope after systemic administration 
but not MS infusion.  While Wells et al. (2013) did not see an effect on theta power after 
systemic BDZ administration, this small difference could be due to differences in 
calculating changes in power.  They looked at subsets of data with similar median 
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running speeds while these results were calculated by finding the theta power within each 
speed bin and fitting a regression line to the data.  However, this effect was relatively 
small in comparison to the change seen in theta frequency. 
No changes were seen in the mean firing rates of any of the principal cell types or 
putative interneurons after systemic injection, similar to what was reported for principal 
cells in the hippocampus as well (Wells et al., 2013).  MS infusion of diazepam did not 
elicit changes either.  No significant differences were seen in any of the firing properties 
of the different types of neurons after either administration method of diazepam.  Despite 
theta frequency in the LFP decreasing significantly, reflections of this could not be found 
in the spacing of grid fields.  This is consistent with predictions made by Burgess (2008) 
that anxiolytics affect Type II theta due it being linked to arousal and anxiety (Sainsbury 
et al., 1987), which would not have an effect on the slope of theta frequency across 
running speeds and therefore grid cell field spacing.  The lack of effects from diazepam 
administration on single unit firing properties highlights the resiliency of MEC cells to 
perturbations in the LFP.  Future studies and analyses could look at LFP-related firing 
properties of grid cells, like seen in phase precession or phase locking, to examine if 
spiking slows down to maintain this relationship but might not be a large enough effect to 
be reflected in the intrinsic rhythmicity measures currently used. 
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3.5. Tables 
Table 3.1. Selection of diazepam doses from the literature given via intraperitoneal 
injection. 
Doses Task Effect Timing Citation 
1.25 and 
2.5 mg/kg 
Social 
interaction test 
and elevated 
plus maze. 
Both doses increased social interaction 
and open arm exploration and larger 
dose decreased motor behavior in both 
experiments. 
30 minutes 
prior to testing. 
Dunn et al. 
(1989) 
1 and 2 
mg/kg 
Elevated plus 
maze. 
Increased open arm traversals, decreased 
motor behavior. 
30 minutes 
prior to testing. 
Pellow et al. 
(1985) 
1 mg/kg Water maze. Impaired retention of platform location 
(spatial information processing). 
30 minutes 
prior to testing. 
Brioni & 
Arolfo 
(1992) 
0.3, 1, 3 
mg/kg 
Water maze. 1 and 3 mg/kg impaired place learning. -- Arolfo & 
Brioni 
(1991) 
 
Table 3.2. Literature review of diazepam concentrations infused into the medial septum 
or other areas of the brain. 
Doses Task Effect Timing Citation 
5, 10, 
and 15 
pmol 
Performed infusions and 
microdialysis to measure 
changes in hippocampal ACh. 
Reduced 
hippocampal ACh 
release by 50%. 
Maximal effect was 20 
min post infusion, 
lasting up to 40 min. 
Imperato et 
al. (1994) 
1 ng Step-down inhibitory 
avoidance task. 
Infusion before 
training produced 
amnesia. 
Infused 20 min before 
training. 
Costa et al. 
(2010) 
 
Table 3.3. Examples from the literature of infusions of diazepam into brain regions other 
than the MS. 
Doses Task Effect Timing Citation 
2 μg in ABLA 
bilaterally or dorsal 
periaqueductal gray 
Anxiolytic effects 
measured with rat 
burying test (received 
shock) and effects on 
nociception effects 
evaluated. 
Reduced burying 
behavior and had 
antinociceptive 
response. 
Infused 15 
min before 
burying 
behavior task. 
Jimenez-
Velazquez 
et al. (2010) 
5 μg bilaterally in 
substantia nigra 
Induced seizures via 
systemic administration 
of soman, which 
irreversably inhibits 
acetylcholinesterase. 
Produced 
anticonvulsant 
effects. 
Infused 20 
min before 
soman 
injection. 
Myhrer et 
al. (2006) 
30 μg in amygdala and 
hippocampus 
Negative contrast-- 
decrease in licking 
behavior when decrease 
sucrose concentration. 
Infusion into 
amygdala but not 
hippocampus 
attenuated negative 
Test 
conducted 
immediately 
after infusion. 
Liao & 
Chuang 
(2003) 
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contrast effect. 
20 ng, 100 ng, up to 5 μg 
unilaterally into locus 
coeruleus or 
intracerebroventricular 
infusion 
Recorded sensory-
evoked activity and 
spontaneous firing rates 
in LC; extracellular 
recordings under 
anesthesia. 
Both infusion 
locations reduced 
spontaneous firing 
rates similar to 
systemic injections 
(though change very 
small); however 
unlike systemic 
injections did not 
attenuate evoked 
activity. 
Infusion 
suggested to 
be just before 
post-drug 
recordings 
began. 
Simson & 
Weiss 
(1989) 
2 or 10 μg into raphe 
medianus in 1 ul, or 15 
μg into dhipp in 3 μl 
Examined effects on 
cerebral serotonin 
synthesis in 
hippocampus, cerebral 
cortex, striatum, 
cerebellum, and spinal 
cord. 
Infusing 15 μg into 
hippocampus 
reduced 5-HT 
synthesis in that 
area.  Infusion into 
raphe medianus did 
not affect 
hippocampal 5-HT 
synthesis. 
Animals 
sacrificed 60 
minutes after 
infusion to 
measure 5-HT 
synthesis. 
Nishikawa 
& Scatton 
(1986) 
30 μg into amygdala 
bilaterally 
Tested post-shock 
freezing and 
hypoalgesia. 
Infusing 30 μg 
bilaterally into 
basolateral 
amygdala attenuated 
both freezing and 
hypoalgesia. 
Infusion (and 
formalin 
injection) 
occurred 25 
minutes 
before 
behavioral 
testing. 
Helmstetter 
(1993) 
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3.6. Figures 
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Figure 3.1.  Systemic injection of diazepam reduces the intercept of theta frequency and 
amplitude.  
 
A. Effects of systemic injection (A1, red line) compared to baseline (black line) and 
recovery sessions (grey lines) on LFP theta frequency plotted across running speeds, and 
the same for vehicle (A2, blue line).  B, C.  Same as A but for theta amplitude and power, 
respectively. 
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Figure 3.2.  Mean firing rate for grid cells, HD cells, theta rhythmic cells, and 
interneurons across sessions. 
 
No significant effects were seen after systemic injection of diazepam (top) and vehicle 
(bottom) on mean firing rate of grid cells, HD cells, theta rhythmic cells, or interneurons.  
Each cell recorded across sessions is marked by a single colored line.  The vertical black 
line represents the standard error of measurement. 
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Figure 3.3.   Mean resultant length of conjunctive and HD cells across sessions. 
 
Directionality of cell firing across sessions for conjunctive grid cells and head direction 
cells after systemic injection of diazepam (top) and vehicle (bottom).  No drug effects on 
directionality of firing for conjunctive head by grid cells or HD cells were seen.  Each 
cell recorded across sessions is marked by a single colored line.  The vertical black line 
represents the standard error of measurement.  
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Figure 3.4.  Spatial periodicity and grid field distances were unaffected by diazepam 
systemic administration. 
 
Gridness score (left) and grid field distance (right) of grid cells after systemic injection of 
diazepam (top) and vehicle (bottom). Each cell recorded across sessions is marked by a 
single colored line.  The vertical black line represents the standard error of measurement.  
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Figure 3.5. Rate maps and rate map autocorrelograms for all 11 grid cells for diazepam 
systemic experiments. 
 
There was no statistical difference between gridness score before versus after 
administration of diazepam.  Warmer colors in the plots indicate higher firing rates in the 
rate maps (top) and higher correlation in the spatial autocorrelation (bottom).  Mean 
firing rate and gridness score are located on top of each plot.  While the bar plot in Figure 
3.4 suggests a number of grid cells lost their tuning after drug administration, 
qualitatively most appear to remain just as spatially periodic as before drug and during 
recovery sessions.  Of note, the first two grid cells in the figure, recorded simultaneously, 
appear to undergo field remapping, returning to the original firing locations during 
recovery sessions.  However, these are the only two examples of this phenomenon across 
all the experiments.  
Pre-Injection Diazepam 3 - 6 hr Recovery 24 hr Recovery
m: 0.51   g: 0.44 m: 0.46   g: −0.10 m: 0.42   g: 0.12
m: 3.50   g: 1.39 m: 2.50   g: 1.14 m: 2.40   g: 1.22
m: 0.32   g: 0.59 m: 0.26   g: −0.45 m: 0.22   g: 0.23 m: 0.49   g: −0.46
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Figure 3.6. Spatial information score and correlation of rate maps of grid cells after 
systemic injection of diazepam and vehicle. 
 
Measures of spatial firing after systemic injection of diazepam (top) and vehicle (bottom) 
for spatial information (left) and spatial correlation of rate maps (right).  Each cell 
recorded across sessions is marked by a single colored line.  The vertical black line 
represents the standard error of measurement. 
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Figure 3.7. Median running speed (cm/s) across recording sessions. 
 
No significant changes in median running speed from baseline to the second recording 
session were seen after administration of diazepam systemic (top) or PBS (vehicle) 
systemic experiments (bottom).  Each session’s median speed is marked by a single 
colored line.  The vertical black line represents the standard error of measurement. 
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Figure 3.8.   A decrease in intrinsic rhythmicity of grid cell firing did not reach 
significance after diazepam injection. 
 
Firing rhythmicity (left) and theta index (right) for systemic injections of diazepam (top) 
and vehicle (bottom).  Each cell recorded across sessions is marked by a single colored 
line.  The vertical black line represents the standard error of measurement. 
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Figure 3.9.  MS infusion of diazepam has no significant effect on LFP theta properties. 
 
A. Effects of MS infusion (A1, red line) compared to baseline (black line) and recovery 
sessions (grey lines) on LFP theta frequency plotted across running speeds, and the same 
for vehicle (A2, blue line).  B, C.  Same as A but for theta amplitude and power, 
respectively. 
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Figure 3.10. Spectrograms of the effects of infusions of muscimol and diazepam, and 
frequency versus speed plots after diazepam and 8-OH-DPAT infusion, for each of the 
four animals. 
Rat ID: cm-16
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Spectrograms demonstrate loss of theta with muscimol but not with diazepam (left), and 
theta frequency versus running speed plots showing a decrease in the intercept of theta 
frequency after 8-OH-DPAT infusion but not diazepam. 
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Figure 3.11.  Mean firing rate for grid cells, HD cells, theta rhythmic cells, and 
interneurons across sessions. 
 
No drug effects were seen after MS infusion of diazepam (top) or vehicle (bottom) on 
mean firing rate of grid cells, HD cells, theta rhythmic cells, or interneurons.  Each cell 
recorded across sessions is marked by a single colored line.  The vertical black line 
represents the standard error of measurement. 
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Figure 3.12.  Mean resultant length of conjunctive and HD cells across sessions. 
 
Directionality of cell firing across sessions for conjunctive grid cells and head direction 
cells after MS infusion of diazepam (top) and vehicle (bottom).  No drug effects on 
directionality of firing for conjunctive head by grid cells or HD cells were seen.  Each 
cell recorded across sessions is marked by a single colored line.  The vertical black line 
represents the standard error of measurement. 
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Figure 3.13.  Spatial periodicity and grid field distances were unaffected by MS infusion 
of diazepam. 
 
Gridness score (left) and grid field distance (right) of grid cells after MS infusion of 
diazepam (top) or vehicle (bottom).  Each cell recorded across sessions is marked by a 
single colored line.  The vertical black line represents the standard error of measurement. 
  
G
ri
dn
es
s S
co
re
-0.5
0
0.5
1
1.5
Spatial Periodicity
Pre-Infusion
Diazepam
3 - 6 hr
24 hr
Field Distance 
40
20
0
G
ri
d 
fie
ld
 
di
st
a
n
ce
 
(cm
)
Pre-Infusion
Diazepam
3 - 6 hr
24 hr
G
ri
dn
es
s S
co
re
-0.5
0
0.5
1
1.5
Spatial Periodicity
G
ri
d 
Fi
el
d 
D
ist
a
n
ce
 
(cm
)
0
20
30
40
Field Distance
Pre-Infusion
PBS
3 - 6 hr
24 hr
Pre-Infusion
PBS
3 - 6 hr
24 hr
 
 
 
101 
DIAZEPAM 
 
 
VEHICLE 
 
 
Figure 3.14. Spatial information score and correlation of rate maps of grid cells after MS 
infusion of diazepam or vehicle. 
 
Measures of spatial firing after MS infusion of diazepam (top) or vehicle (bottom) for 
spatial information (left) and spatial correlation of rate maps (right).  Each cell recorded 
across sessions is marked by a single colored line.  The vertical black line represents the 
standard error of measurement.  
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Figure 3.15. Median running speed (cm/s) across recording sessions significantly 
decreased after diazepam infusion. 
 
A significant decrease in median running speed was seen after MS infusion of diazepam 
(top) in comparison to vehicle (bottom).  Each session’s median speed is marked by a 
single colored line.  The vertical black line represents the standard error of measurement. 
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Figure 3.16.  No significant differences were seen in intrinsic rhythmicity or theta index 
after diazepam infusion. 
 
Firing rhythmicity (left) and theta index (right) for MS infusions of diazepam (top) and 
vehicle (bottom).  Each cell recorded across sessions is marked by a single colored line.  
The vertical black line represents the standard error of measurement. 
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CHAPTER 4: Conclusion 
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4.1. Implications 
Findings from this work suggest that the BDZ and serotonergic anxiolytic-
induced decrease of theta frequency can be expanded from detection in hippocampal LFP 
theta to the MEC as well.  There was a robust and significant decrease in the intercept of 
the regression line of the relationship between theta frequency and running speed as 
recorded in the LFP in the MEC for both types of anxiolytics when given systemically.  
The only effect seen on slope was after systemic administration of 8-OH-DPAT where it 
did not demonstrate an increase in slope common to multiple same day exposure sessions.  
However, it did not statistically differ from baseline and therefore was not outside a 
natural range of values.  The effects of the drugs when given systemically on the intercept 
of theta frequency across running speeds largely corroborate recent data from Wells et al. 
(2013) from the hippocampus, despite recording in a different region and using different 
drugs within the two classes. 
The findings that subthreshold membrane potential oscillations in layer II stellate 
cells are positively correlated with increasing depolarization, and the slope of the 
frequency versus depolarization relationship decreases for cells recorded at more ventral 
positions along the dorsoventral axis (also corresponding to changes in grid scale along 
the same axis) (Giocomo et al., 2007), has been used as evidence supporting the OIM 
(Burgess, 2008).  Burgess (Burgess, 2008) also predicted a dissociation between the slope 
and intercept of the relationship between theta frequency and running speed and that 
specifically, changes in slope but not intercept would produce changes in grid scale.  
Given the evidence showing anxiolytics decrease not only theta frequency in general, but 
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also the slope of the relationship between frequency and the magnitude of stimulation in 
reticular stimulation evoked theta, it was thought that grid scale could be affected by 
anxiolytics as well.  However, recent evidence specifically looking at the effects of 
anxiolytics on hippocampal theta frequency across running speeds has shown that the 
overall anxiolytic induced decrease in theta frequency comes from a decrease in the 
intercept of this relationship and not a change in slope (Wells et al., 2013).  Therefore, if 
the same relationship holds true in the MEC then one would not expect a change in grid 
scale after administration of anxiolytics despite an overall decrease in theta frequency, 
based on this model.  In line with this, these results support these predictions.  Despite an 
overall decrease in mean theta frequency, no changes in grid scale were seen.  Much like 
hippocampal results reported by Wells et al. (2013), systemic administration of both a 
serotonergic anxiolytic and a BDZ decreased the intercept of the relationship between 
theta frequency and running speed, but not the slope. 
Results from this work did produce the novel finding that serotonergic anxiolytics 
could exert effects on theta frequency through the MS while BDZs cannot.  Interestingly, 
in a septo-hippocampal model of the Wells et al. (2013) results, increasing synaptic 
conductance in the GABA-A mediated synapses was unable to produce changes in theta 
frequency, suggesting that systemic effects of BDZs on hippocampal theta might be 
mediated outside of the circuit (John et al., 2014).  This could support the negative 
finding of a lack of effect after MS infusion of diazepam on MEC theta frequency despite 
a significant decrease following systemic administration.  John et al. (2014) suggest the 
reduction could be mediated by medial hypothalamic sites, such as the medial 
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supramammillary nucleus, since infusion of a BDZ into that location mimics systemic 
administration results (Woodnorth and McNaughton, 2002).  Future research could 
confirm this by recording MEC activity after infusing a BDZ into the supramammillary 
nucleus and comparing to systemic results. 
Unlike infusions of diazepam, infusion of 8-OH-DPAT produced a statistically 
significant decrease in the intercept of theta frequency across running speeds, suggesting 
the mechanism of action underlying systemic effects of the drug could in some way be 
mediated through the MS.  It is not clear if the MS is solely responsible for the drug 
action on theta frequency.  While the decrease in theta frequency appears to be somewhat 
smaller than for systemic administration, this study did not look at the effects of different 
doses, which could affect the extent of the decrease in frequency.  Furthermore, the 
median raphe nuclei provide dense serotonergic and non-serotonergic innervation of the 
MEC, hippocampus, and septal nuclei (Köhler and Steinbusch, 1982; Köhler et al., 1982), 
and manipulation of the median raphe can affect hippocampal theta rhythm (Kinney et al., 
1994; Vertes et al., 1994).  It is possible that systemic effects are mediated through the 
raphe nuclei and the MS is simply capable of, but not required for, producing effects on 
MEC theta frequency. 
Systemic administration or MS infusion of diazepam did not appear to affect any 
single unit properties of grid cells, including spatial periodicity.  MS infusions of the 
GABA-A agonist, muscimol, greatly reduce theta power and grid cell spatial periodicity 
(Brandon et al., 2011), however, it appears that despite positively modulating the same 
receptor, diazepam does not have the same effect.  As diazepam is a positive modulator 
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of GABA-A receptors, working through the BDZ site, the extent of its effects are limited 
by the GABA release of an afferent neuron.  Unlike muscimol, application of this drug to 
an area does not necessarily silence it through inhibiting local neurons and therefore its 
potential effects may be limited that way.   
The only effect on a single unit firing property across all experiments was a 
decrease in the intrinsic rhythmicity found the firing of grid cells after 8-OH-DPAT 
systemic administration.  It is possible this decrease is due to phase locking of grid cell 
firing to LFP theta.  As LFP theta frequency decreases, if the cell maintains phase locking 
then it should slow its rhythmic firing slightly.  That this effect is seen in systemic but not 
MS infusion of 8-OH-DPAT could reflect the magnitude of decrease necessary for the 
sensitivity of picking up this small change in firing.  The figure showing the effects of 
MS infusion of 8-OH-DPAT does suggest a trend, but again does not reach significance 
(Figure 2.14, top left).  While systemic administration of diazepam robustly decreased 
LFP theta frequency as well, there was not a significant change in the intrinsic 
rhythmicity of grid cell firing.  However, the figure showing the change in rhythmicity 
(Figure 3.8, top left) does appear to show a trend, very similar to 8-OH-DPAT systemic 
administration, except for one cell.  It could be that this outlier could be affecting what 
would otherwise be a significant effect, which increasing the sample size could address.  
Overall however, it appears that except in one single case, neither anxiolytic is able to 
produce changes in single unit firing properties—the mechanisms underlying their 
activity appear robust to anxiolytic-induced perturbations of the system. 
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4.2. Future directions 
The data presented here are preliminary and increasing the sample size will help 
clarify and solidify effects.  Furthermore, infusions of DMSO (diazepam vehicle) will be 
necessary to ensure the compound is not neutralizing any potential effects that might 
otherwise be seen, corroborating previously reported data in the literature that showed no 
effects from DMSO infusions on activity. 
Ideally, it would also be interesting to observe effects on phase precession of grid 
cell firing, where spikes occur at earlier phases as an animal traverses through a grid 
cell’s receptive field.  However, due to the angle of approach toward the MEC, tetrodes 
pass through deeper layers first and make recording from phase precession-rich layer II 
less likely.   
The finding that MS infusion of diazepam did not have an effect on MEC theta 
frequency supports the theory that benzodiazepines exert their frequency modulating 
effects through other nuclei, possibly the supramammillary nucleus (Woodnorth and 
McNaughton, 2002).  An obvious next step from this would be to infuse a BDZ into the 
supramammillary nucleus and record MEC theta, looking for changes in frequency.  An 
interesting addition to this might be to also test other anxiolytics, such as serotonergic-
based ones.  Since application of serotonergic 1A receptor agonists into the median raphe, 
which provides serotonergic input throughout the brain, disrupts hippocampal theta 
instead of modulating it, this suggests the anxiolytic-induced decrease in theta frequency 
by serotonergic anxiolytics could be mediated elsewhere.  The medial supramammillary 
nucleus receives cholinergic input from medial septum and serotonergic input from 
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dorsal raphe (Gonzalo-Ruiz et al., 1999), so it is possible the effects of serotonergic 
anxiolytics could be mediated through this region. 
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